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ABSTRACT
Integral membrane transport proteins are essential for the transport of a wide variety of
substrates such as ions, drugs and metabolites across the membranes of microorganisms. They
are found in diverse locations such as outer and inner membranes of archaeal, prokaryotic and
eukaryotic cells, as well as the outer layers of the membrane-bound organelles, including
chloroplasts, endoplasmic reticulum and mitochondria. These proteins are capable of facilitating
the transport of substrates both from outside the cell to inside, and vice versa, and they can be
very specific, thereby playing a significant role in substrate selection. Integral membrane
transport proteins also play important roles in regulation of transport, defense against drugs and
antibiotics, and hemostasis. Thus, understanding the structural framework and detailed functional
mechanisms of these proteins will contribute to our knowledge of biological processes.
In this study, we have investigated the structure, function and regulation of three different
types of integral membrane transport proteins. Chapter 2 focuses on elucidating the structure and
function of the transcriptional regulator Rv0678 of Mycobacterium tuberculosis, which
negatively regulates the expression of the MmpS4-MmpL4 system, which plays a key role in the
biosynthesis and transport of lipids from the cytoplasm towards the periplasm. Lipids play an
important role in cell wall remodeling and permeability, thereby functioning in bacterial defense
against antibiotics. We crystallized Rv0678 and identified the ligand bound to the protein as 2-
stearoylglycerol. We used the structure and functional studies to elucidate a possible DNA
binding mechanism for the protein. Chapter 3 discusses the crystal structure of the outer
membrane channel, CmeC, of CmeABC efflux system of Campylobacter jejuni. CmeABC is a
multidrug efflux system that pumps out quinolones and bile acid derivatives. The crystal
structure revealed the structural framework of the channel and captured it in closed
conformation. Chapter 4 focuses on understanding the structural basis of nitrite transport into the
chloroplast in Chlamydomonas reinhardtii. Formate-nitrite transporter family proteins, NAR1.1
and NAR1.5, were crystallized using hanging drop vapor diffusion. Stopped flow light scattering
experiments were carried out to identify nitrite as the substrate for both proteins. Site-directed
mutagenesis revealed key residues that form the channel and allowed us to propose a possible
nitrite transport mechanism.
1CHAPTER 1. GENERAL INTRODUCTION
Bacterial infections cause millions of deaths every year [1]. Over the past century, scientists
have successfully employed novel antibiotics to treat these infections and combat the spread of the
bacterial pathogens [1, 2]. However, over the years, bacterial pathogens have evolved various
mechanisms to help them survive the effects of the antibiotics [3, 4]. The emergence of drug
resistant strains of bacterial pathogens have rendered existing antibiotics less effective and signals
the need for new therapeutic ways to combat them [5-9]. Understanding the mechanisms of
bacterial drug resistance is of paramount importance in this regard. Chapter 2 and 3 of this
dissertation focusses on understanding the bacterial drug resistance mechanisms in Mycobacterium
tuberculosis and Campylobacter jejuni using X-ray crystallography and other biophysical
techniques. Chapter 4 describes the structural and functional studies of nitrite channels NAR1.1
and NAR1.5 of Chlamydomonas reinhardtii.
Mycobacterium tuberculosis (Mtb) is the causative agent for tuberculosis, a disease that
infects approximately 8 million people annually [10]. The emergence of new strains of Mtb that
are resistant to existing antibiotics has made tuberculosis treatment cumbersome [5, 9]. This
precarious situation has forced scientists across the world to look for new therapeutic pathways to
combat the virulence of Mtb inside the host cell. One of these new pathways is restricting the
availability of iron, an important nutrient for the virulence of bacterial pathogens such as Mtb [11-
13]. The only source of iron for Mtb is the host cell, but the availability of iron to the pathogen is
often restricted by the host immune system [14, 15].
2Mtb employs two classes of molecules, mycobactins and carboxymycobactins, also called
siderophores, to capture iron from the host cell [16]. Recent studies have revealed two proteins,
mycobacterial membrane protein small (MmpS) and mycobacterial membrane protein large
(MmpL), that are involved in scavenging iron from the host cell [17]. Although mycobacteria
cluster phylogenetically with gram-positive prokaryotes, they are structurally more similar to
gram-negative bacteria. Unlike the resistance nodulation and cell division (RND) efflux pumps of
gram-negative bacteria, which pump out a wide range of substrates, MmpL-MmpS systems do not
usually participate in antibiotic efflux [18]. Instead, they are believed to participate in Mtb iron
acquisition [17]. There is direct evidence that mycobactins, the lipophilic siderophores of
mycobacteria, efficiently extract intracellular macrophage iron [16]. The metal free siderophore of
mycobacteria is diffusely associated with the macrophage membrane, ready for chelation. When
iron is bound, the siderophore is ready to be transported into the mycobacteria. Two of the MmpS-
MmpL systems, MmpS4-MmpL4 and MmpS5-MmpL5, are the most characterized members of
this family [17]. Studies using cytoplasmic iron reporter indicate that ∆mmpS4/S5 mutants
experience iron starvation even under high iron conditions. The double mutant was also impaired
in biosynthesis and secretion of siderophores [17]. MmpS4 is localized in the periplasm [19] and
interacts with the periplasmic loop of the mmpL4 protein [17].  MmpS5 also binds to the
periplasmic loop of MmpL5 [17]. Structurally MmpS proteins resemble the periplasmic adaptor
proteins of the tripartite efflux systems of gram-negative bacteria.
The expression of the MmpS5-MmpL5 efflux system is controlled by a transcriptional
regulator, Rv0678, which helps Mtb adapt to changes in the environment. Rv0678 is located
downstream of the mmpS5-mmpL5 operon and belongs to the MarR family of regulators [20]. The
3MarR family of regulators is found in bacteria and archaea and regulates numerous biological
functions. MarR regulators possesses a DNA binding domain formed by a typical winged helix-
turn-helix binding motif, a dimerization domain, and a substrate binding region located between
the DNA binding domain and the dimerization domain [21]. When not liganded, the MarR
regulator is capable of binding to DNA. Understanding the structural details of Rv0678 will be
key to understanding the mechanism of regulation and function of the MmpS5-MmpL5
siderophore efflux system and will aid in designing novel drugs to combat the highly pathogenic
Mtb.
Campylobacter jejuni causes the acute diarrheal disease, human enterocolitis, especially in
infants, and causes about 400 million infections every year [22]. Macrolide and quinolone
derivatives are used as antimicrobial agents to treat the C. jejuni infection [23]. In a major public
health concern, recent studies reveal increased resistance of the pathogen to the existing antibiotics
[4]. Antibiotic efflux systems, as one of these resistance mechanisms, extrude structurally diverse
antimicrobial agents out of the bacterial cell [24, 25]. Identifying the antimicrobial efflux systems
of C. jejuni and elucidating its structural details is of significant clinical importance. Scientists
have characterized an efflux pump, cmeABC, encoded by a three gene operon, which contributes
significantly to multidrug resistance in C. jejuni [26-28]. Studies have shown that inactivation of
CmeABC greatly reduces the frequency of emergence of quinolone resistant mutants, whereas its
overexpression increases the frequency [29]. Sequence analysis of cmeABC revealed significant
resemblance to multidrug efflux systems of other gram-negative bacteria. It consists of a
periplasmic membrane fusion protein, CmeA, an inner membrane efflux pump of the resistance-
nodulation-cell division (RND) superfamily, CmeB, and an outer membrane channel protein,
4CmeC. The efflux complex spans the entire cell membrane. Understanding the structure of the
individual components of CmeABC will be valuable in designing novel antibiotics.
Chlamydomonas reinhardtii is a photosynthetic single celled green alga widely distributed
in soil and fresh water. It possesses a large cup-shaped chloroplast that enables it to perform
photosynthesis. C. reinhardtii requires carbon dioxide (CO2) and bicarbonate (HCO3-), two
utilizable forms of inorganic carbon (Ci) for photosynthesis [30, 31]. For aquatic photosynthetic
organisms, such as C. reinhardtii, the supply of CO2 can change dramatically. C. reinhardtii
possesses a carbon concentrating mechanism (CCM) to survive in carbon limiting environments
[32]. Membrane proteins belonging to different classes take part in CCM in C. reinhardtii.
An important step in the nitrate assimilation in C. reinhardtii also takes place in the
chloroplast, where nitrite is reduced to ammonium, which is incorporated into the carbon skeleton
[33]. Nitrite hemostasis is significant because nitrite accumulation can be toxic to most cells.
Nitrite can be reduced to the nitric oxide (NO) radical, which is cytotoxic and can cause damage
to DNA and iron-sulfur clusters [34-36]. Therefore, structural studies of membrane proteins
involved in nitrite transport are important. .
Gene expression analysis of CCM induction in C. reinhardtii has revealed that multiple
transporters are involved in Ci uptake [37]. Nar1 codes for proteins belonging to the formate-nitrite
transporter (FNT) family and encodes six genes; Nar1.1, Nar1.2, Nar1.3, Nar1.4, Nar1.5 and
Nar1.6. Out of the six FNT family proteins, NAR1.1, NAR1.2 (also called LCIA), and NAR1.5
are believed to be located at the chloroplast envelope membrane [38]. They are proposed to serve
as nitrite/bicarbonate channels that conduct these anions across the chloroplast envelope
membrane. These three proteins share high sequence similarity with each other and are predicted
5to have a long transit peptide and six transmembrane regions [38]. Proteins belonging to the FNT
family are found commonly in bacteria, but are less frequently found in eukaryotic organisms such
as fungi, yeast, algae and protozoa [38]. Understanding the structure and function of these proteins
will help us understand the transport mechanism of nitrite and bicarbonate across the chloroplast
membrane.
Thesis organization
Chapter 1 is a brief general introduction that provides background information
about the transcriptional regulator Rv0678 of Mycobacterium tuberculosis, the outer
membrane channel CmeC of the CmeABC efflux system of Campylobacter jejuni, and
nitrite channels, NAR1.1 and NAR1.5, of the photosynthetic green algae Chlamydomonas
reinhardtii.
Chapter 2 is a manuscript published in Journal of Biological Chemistry, describing
the role of Rv0678 in regulating the expression MmpS5-MmpL5 efflux system in M.
tuberculosis. The ligand bound to the Rv0678 dimer was identified using gas
chromatography–mass spectrometry (GC-MS). Electrophoretic mobility shift assay
(EMSA) and florescence polarization studies of Rv0678 with the promoter region of the
rv0678-mmpS5 operon revealed a possible DNA binding mechanism for the MarR family
regulators. Cloning of rv0678 was done by HT Lei. Expression, purification and
crystallization was carried out by N. Kumar and myself. Model building and structural
refinement was done by TH Chou and CC Su.
Chapter 3 is a manuscript published in Protein Science, describing the crystal
6structures of C. jejuni CmeC, an outer membrane protein of CmeABC, a multidrug efflux
system belonging to RND family. The crystal structures consists of a β barrel and an α-
helical bundle, typical of the RND family. I carried out the cloning, expression,
purification and crystallization of cmeC in collaboration with CC Su and N Kumar. Model
building and structural refinement was done by CC Su.
Chapter 4 investigates the crystal structures of nitrite channels, NAR1.1 and
NAR1.5, of C. reinhardtii, which belong to FNT family. The proteins are located in the
chloroplast envelope membrane and conduct nitrite ion from cytoplasm to stroma.
Stopped flow light scattering experiments were done to identify the substrate as well as
the key residues involved in anion transport. Cloning of nar1.1 and nar1.5, expression,
purification and crystallization of NAR1.1 and NAR1.5 were carried out by me. Model
building and structural refinement was done by TH Chou. Stopped flow light scattering
experiment and data analysis was done by TH Chou and me.
Chapter 5 summarizes the conclusions and significance of these studies and
outlines directions for future research.
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Abstract
Recent work demonstrates that the Mycobacterial membrane protein large (MmpL)
transporters are dedicated to the export of mycobacterial lipids for cell wall biosynthesis.  An
MmpL transporter frequently works with an accessory protein, belonging to the Mycobacterial
membrane protein small (MmpS) family, to transport these key virulence factors. One such
efflux system in Mycobacterium tuberculosis is the MmpS5-MmpL5 transporter. The
expression of MmpS5-MmpL5 is controlled by the MarR-like transcriptional regulator
Rv0678, whose open reading frame is located downstream of the mmpS5-mmpL5 operon. To
elucidate the structural basis of Rv0678 regulation, we have determined the crystal structure of
this regulator, to 1.64 Å resolution, revealing a dimeric two-domain molecule with an
architecture similar to members of the MarR family of transcriptional regulators.  Rv0678 is
distinct from other MarR regulators in that its DNA-binding and dimerization domains are
clustered together. These two domains seemingly cooperate to bind an inducing ligand that we
identified as 2-palmitoylglycerol, which is a fatty acid glycerol ester.  The structure also
suggests that the conformational change leading to substrate-mediated derepression is
primarily caused by a rigid body rotational motion of the entire DNA-binding domain of the
regulator towards the dimerization domain.  This movement results in a conformational state
that is incompatible with DNA binding. We demonstrate using electrophoretic mobility shift
assays that Rv0678 binds to the mmpS5-mmpL5, mmpS4-mmpL4 and the mmpS2-mmpL2
promoters. Binding by Rv0678 was reversed upon addition of the ligand. These findings
provide new insight into the mechanisms of gene regulation in the MarR family of regulators.
Introduction
Tuberculosis (TB) is one of the oldest described diseases and remains a significant
global problem with more than eight million new cases reported annually (1).  The World
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Health Organization estimates that one-third of the world’s population is infected with M.
tuberculosis, and most of these individuals have latent TB (2).  TB treatments are notoriously
difficult and are compromised by the emergence of multiple drug-resistant (MDR), extensively
drug-resistant (XDR) and totally drug-resistant (TDR) bacterial strains (3-7).  The development
of drug-resistant M. tuberculosis strains is a major threat that challenges global prospects for
TB control.
Although mycobacteria cluster phylogenetically with Gram-positive prokaryotes, they
are structurally more similar to Gram-negative bacteria.  These mycobacteria are protected by
an outer lipid bilayer made of mycolic acids and a cell envelope composed of non-covalently
bound lipids and glycolipids.  The unique structure and composition of the cell wall
differentiates this highly pathogenic microorganism from other prokaryotes.  The
mycobacterial cell wall plays a crucial role in the host-pathogen interface on several levels (8).
First, the thick, greasy cell wall acts as an effective layer of protection, providing intrinsic
resistance to antibiotics and bactericidal components of the host immune response.  Second,
the surface-exposed polyketide and glycoconjugate lipids of the M. tuberculosis cell wall are
associated with bacterial virulence (9-12).
The genome of M. tuberculosis H37Rv contains 15 genes that encode the resistance-
nodulation-cell division (RND) proteins designated MmpL transporters (13, 14).  Unlike the
RND-type efflux pumps of Gram-negative bacteria, MmpL proteins do not usually participate
in antibiotic efflux.  Instead, there is strong evidence that these MmpL proteins are responsible
for exporting fatty acids and lipidic elements of the cell wall (8, 9, 12, 15-17).  Five mmpL
genes are located adjacent to genes coding for proteins involved in fatty acid or polyketide
synthesis, suggesting that the MmpL membrane proteins transport these key virulence factors
(9, 10).  Similar to RND proteins of Gram-negative bacteria, the MmpL transporters of M.
tuberculosis are believed to work in conjunction with accessory proteins.  Specifically, MmpL
15
transporters form complexes with the MmpS-family proteins in order to export cell wall lipid
constituents (18). Five genes encoding MmpS proteins are adjacent to genes encoding MmpL
proteins (8, 13).  Work in the model organism M. smegmatis demonstrated that MmpS4 was
required for bacterial sliding motility and biofilm formation (19).  That the mmpS4 and mmpL4
mutants had similar phenotypes underscore a coordinated function for cognate MmpS-MmpL
proteins.
Our efforts have focused on elucidating how M. tuberculosis transport systems are
regulated.  We previously crystallized the Rv3066 efflux regulator both in the absence and
presence of bound substrate (20).  Our data indicated that ligand binding triggers a rotational
motion of the regulator, which in turn releases the cognate DNA and induces the expression of
the Mmr efflux pump (20).  We report here the crystal structure of the Rv0678 regulator, which
has been proposed to control the transcriptional regulation of the MmpS5-MmpL5 transport
system. Rv0678 belongs to the MarR family of regulators, which are found ubiquitously in
bacteria and archaea and control various important biological processes, such as resistance to
antimicrobials, sensing of oxidative stress agents and regulation of virulence factors (21).
Typically, the MarR-family regulators are dimeric in form and their protein sequences are
poorly conserved.  However, these proteins share a common fold, consisting of a helical
dimerization domain and two winged helix-turn-helix (wHtH) DNA-binding domains within
the dimer (22). Our data suggest that fatty acid glycerol esters are the natural ligands of the
Rv0678 regulator.  Electrophoretic mobility shift assay indicates that Rv0678 binds promoters
of the mmpL2, mmpL4 and mmpL5 operons.  These results emphasize the importance of the
Rv0678 regulator, which appears to regulate multiple MmpL transport systems.
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Experimental procedures
Cloning of rv0678
The rv0678 ORF from genomic DNA of M. tuberculosis strain H37Rv was amplified
by PCR using the primers 5-CCATGGGCAGCGTCAACGACGGGGTC-3 and 5-
GGATCCTCAGTGATGATGATGATGATGGTCGTCCTCTCCGGTTCG-3 to generate a
product that encodes a Rv0678 recombinant protein with a 6xHis tag at the C-terminus.  The
corresponding PCR product was digested with NcoI and BamHI, extracted from the agarose
gel, and inserted into pET15b as described by the manufacturer (Merck KGaA, Darmstadt,
Germany).  The recombinant plasmid (pET15brv0678) was transformed into DH5 cells and
the transformants were selected on LB agar plates containing 100 g/ml ampicillin.  The
presence of the correct rv0678 sequence in the plasmid construct was verified by DNA
sequencing.
Expression and purification of Rv0678
Briefly, the full-length Rv0678 protein containing a 6xHis tag at the C-terminus was
overproduced in E. coli BL21(DE3) cells possessing pET15brv0678.  Cells were grown in 6
L of Luria Broth (LB) medium with 100 g/ml ampicillin at 37oC.  When the OD600 reached
0.5, the culture was treated with 0.2 mM isopropyl--D-thiogalactopyranoside (IPTG) to
induce Rv0678 expression, and cells were harvested within 3 h.  The collected bacterial cells
were suspended in 100 ml ice-cold buffer containing 20 mM Na-HEPES (pH 7.2) and 200 mM
NaCl, 10 mM MgCl2 and 0.2 mg DNase I (Sigma-Aldrich).  The cells were then lysed with a
French pressure cell.  Cell debris was removed by centrifugation for 45 min at 4oC and 20,000
rev/min.  The crude lysate was filtered through a 0.2 m membrane and was loaded onto a 5
ml Hi-Trap Ni2+-chelating column (GE Healthcare Biosciences, Pittsburgh, PA) pre-
equilibrated with 20 mM Na-HEPES (pH 7.2) and 200 mM NaCl.  To remove unbound proteins
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and impurities, the column was first washed with six column volumes of buffer containing 50
mM imidazole, 250 mM NaCl, and 20 mM Na-HEPES (pH 7.2).  The Rv0678 protein was
then eluted with four column volume of buffer containing 300 mM imidazole, 250 mM NaCl,
and 20 mM Na-HEPES (pH 7.2).  The purity of the protein was judged using 12.5% SDS-
PAGE stained with Coomassie Brilliant Blue.  The purified protein was extensively dialyzed
against buffer containing 100 mM imidazole, 250 mM NaCl, and 20 mM Na-HEPES (pH 7.5),
and concentrated to 20 mg/ml.
Crystallization of Rv0678
All crystals of the 6xHis Rv0678 regulator were obtained using hanging-drop vapor
diffusion.  The Rv0678 crystals were grown at room temperature in 24-well plates with the
following procedures.  A 2 l protein solution containing 20 mg/ml Rv0678 protein in 20 mM
Na-HEPES (pH 7.5), 250 mM NaCl and 100 mM imidazole was mixed with a 2 l of reservoir
solution containing 28% polyethylene glycol (PEG) 1000, 0.1 M Na-acetate (pH 4.0), 0.2 M
NaCl and 10% glycerol.  The resultant mixture was equilibrated against 500 l of the reservoir
solution.  Crystals grew to a full size in the drops within two weeks.  Typically, the dimensions
of the crystals were 0.2 mm x 0.05 mm x 0.05 mm.  Cryoprotection was achieved by raising
the PEG 1000 concentration stepwise to 35% with a 3.5% increment in each step.  Crystals of
the tungsten derivative was prepared by incubating the crystals of Rv0678 in solution
containing 28% PEG 1000, 0.1 M Na-acetate (pH 4.0), 0.2 M NaCl, 10% glycerol and 1 mM
(NH4)2W6(-O)6(-Cl)6Cl6 for 24 hours at 25oC.
Data collection, structural determination and refinement
All diffraction data were collected at 100K at beamline 24ID-E located at the Advanced
Photon Source, using an ADSC Quantum 315 CCD-based detector.  Diffraction data were
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processed using DENZO and scaled using SCALEPACK (23).  The crystals of Rv0678 belong
to the space group P1 (Table 1).  Based on the molecular weight of Rv0678 (18.34 kDa), the
asymmetric unit is expected to contain four regulator molecules with a solvent content of
45.26%.  Six tungsten cluster sites were identified using SHELXC and SHELXD (24) as
implemented in the HKL2MAP package (25).  Single isomorphous replacement with
anomalous scattering (SIRAS) was employed to obtain experimental phases using the program
MLPHARE (26, 27).  The resulting phases were then subjected to density modification and
NCS averaging using the program PARROT (28).  The phases were of excellent quality and
allowed for tracing of most of the molecule in PHENIX AutoBuild (29), which led to an initial
model with over 90% amino acid residues containing side-chains.  The remaining part of the
model was manually constructed using the program Coot (30).  Then, the model was refined
using PHENIX (29) leaving 5% of reflections in Free-R set.  Iterations of refinement using
PHENIX (29) and CNS (31) and model building in Coot (30) lead to the current model, which
consists of two dimers (totally 587 residues in the asymmetric unit) with excellent geometrical
characteristics (Table 1).
Identification of fortuitous ligand
To identify the nature of the bound ligand in crystals of Rv0678, we used gas
chromatography coupled with mass spectrometry (GC-MS). The Rv0678 crystals were
extensively washed with the crystallization buffer and transferred into deionized water. The
mixture was then incubated at 100oC for 5 min, then chloroform was added into the mixture to
a final concentration of 80% (v/v) to denature the protein and allow for the extraction of ligand.
GC-MS analysis indicated that the mass of the bound ligand was octadecanoic acid, 2-
hydroxyl-1-(hydroxymethyl)ethyl ester, also called 2-palmitoylglycerol.
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Virtual ligand screening using AutoDock Vina
AutoDock Vina (32) was used for virtual ligand screening of a variety of compounds.
The docking area was assigned visually to cover the internal cavity of the Rv0678 dimer.  A
grid of 35 Å × 35Å × 35Å with 0.375 Å spacing was calculated around the docking area for all
atom types presented in the DrugBank (33) and ZINC (34) libraries using AutoGrid.  The
iterated local search global optimizer algorithm was employed to predict the binding free
energies for these compounds.
Isothermal titration calorimetry for ligand binding – We used isothermal titration calorimetry
(ITC) to determine the binding affinity of 1-stearoyl-rac-glycerol (an isomer of 2-
palmitoylglycerol) to the purified Rv0678 regulator. Measurements were performed on a VP-
Microcalorimeter (MicroCal, Northampton, MA) at 25 oC.  Before titration, the protein was
thoroughly dialyzed against buffer containing 10 mM Na-phosphate pH 7.2, 100 mM NaCl
and 0.001% DDM. The protein concentration was determined using the Bradford assay.  The
dimeric Rv0678 sample was then adjusted to a final concentration of 400 M and served as the
titrant.  The ligand solution contained 20 M 1-stearoyl-rac-glycerol, 10 mM Na-phosphate
pH 7.2, 100 mM NaCl and 0.001% DDM. The protein and ligand samples were degassed before
they were loaded into the cell and syringe.  Binding experiments were carried out with the
ligand solution (1.5 ml) in the cell and the protein solution as the injectant.  Ten microliter
injections of the ligand solution were used for data collection.
Injections occurred at intervals of 300 s, and the duration time of each injection was 20
s.  Heat transfer (cal/s) was measured as a function of elapsed time (s).  The mean enthalpies
measured from injection of the ligand in the buffer were subtracted from raw titration data
before data analysis with ORIGIN software (MicroCal).  Titration curves were fitted by a
nonlinear least squares method to a function for the binding of a ligand to a macromolecule.
Nonlinear regression fitting to the binding isotherm provided us with the equilibrium binding
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constant (KA = 1/KD) and enthalpy of binding (∆H).  Based on the values of KA, the change in
free energy (∆G) and entropy (∆S) were calculated with the equation: ∆G = - RT lnKA = ∆H -
T∆S, where T is 273 K and R is 1.9872 cal/K per mol.  Calorimetry trials were also carried out
in the absence of Rv0678 in the same experimental conditions.  No change in heat was observed
in the injections throughout the experiment.
Electrophoretic mobility shift assay
Probes were amplified from the H37Rv genome using the primers listed in Table 2.  All
probes were labeled with Digoxigenin using the Roche DIG Gel Shift kit. For EMSA analysis,
12 nM Dig-labeled probe and the indicated micromolar concentrations of protein were
incubated for 45 minutes at room temperature in the Roche binding buffer modified by the
addition of 0.25 mg/mL herring sperm DNA, and 0.75 mg/mL poly(d[I-C]). For ligand
competition studies, 1-stearoyl-rac-glycerol (an isomer of 2-palmitoylglycerol) (Sigma-
Aldrich) was resuspended in hot acetone and added to EMSA reactions at 1 M final
concentration.  Competition reactions were performed at 37oC.  All reactions were resolved on
a 6% native polyacrylamide gel in TBE buffer, transferred to nylon membrane and Dig-labeled
DNA-protein complexes detected following the manufacturer’s recommendations.
Chemiluminescent signals were acquired using an ImageQuant LAS 4000 (GE).
Dye primer based DNase I footprint assay
DNase I foot printing was performed as described by Zianni et al. (35). The 296 bp
Rv0678-mmpS5 probe was generated by PCR using the primers 6FAM-Rv0678-F and HEX-
Rv0678-R. Gel purified, fluorescently labeled probe (0.6 pmol) was incubated with either 1
M Rv0678 or BSA for 30 min at room temperature in standard EMSA binding buffer. After
incubation, 10 mM MgCl2 and 5 mM CaCl2 were added to the reaction mixture in a final
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volume of 50 l. Then, 0.0025 U of DNase I (Thermo) was added and incubated for 5 minutes
at room temperature. Digested DNA fragments were purified with QIAqick PCR Purification
columns (Qiagen) and eluted in 20 l water. Digested DNA samples were analyzed at the
Center for Genome Research and Biocomputing at Oregon State University. Purified DNA (2
mL) was mixed with HiDi formamide and GeneScan-500 LIZ size standards (Applied
Biosystems) and analyzed using an Applied Biosystems 3730 DNA analyzer.
The 296 bp fragment was sequenced with the primers 6FAM-Rv0678-F and HEX-
Rv0678-R, respectively, using the Thermo Sequenase Dye Primer Manual Cycle Sequencing
Kit according to the manufacturer’s instructions. Each reaction was diluted 5-fold in water, and
4 l was added to 5.98 l HiDi formamide and 0.02 l GeneScan-500 LIZ size standard.
Samples were analyzed using the 3730 DNA analyzer and electropherograms aligned using the
GENEMAPPER software (version 5.0, Applied Biosystems).
Site-directed mutagenesis
Site-directed point mutations on residues D90 and R92, which are expected to be
critical for DNA binding, were performed to generate the single point mutants D90A and
R92A.  The primers used for these mutations are listed in Table 3. All oligonucleotides were
purchased from (Integrated DNA Technologies, Inc., Coralville, IA) in a salt-free grade.
Fluorescence polarization assay for DNA binding
Fluorescence polarization assays were used to determine the affinity for DNA binding
by Rv0678 and its mutants.  Both the 26-bp oligodeoxynucleotide and fluorescein labeled
oligodeoxynucleotide were purchased from Integrated DNA Technologies, Inc. (Coralville,
IA). These oligodeoxynucleotides contain the consensus 18-bp putative promoter DNA
sequence (TTTCAGAGTACAGTGAAA) for Rv0678.  The sequences of the
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oligodeoxynucleotides were 5-CAGATTTCAGAGTACAGTGAAACTTG-3 and 5-F-
CAAGTTTCACTGTACTCTGAAATCTG-3, where F denotes the fluorescein which was
covalently attached to the 5 end of the oligodeoxynucleotide by a hexamethylene linker.  The
26-bp fluoresceinated ds-DNA was prepared by annealing these two oligodeoxynucleotides
together.  Fluorescence polarization experiment was done using a DNA binding solution
containing 10 mM Na-phosphate (pH 7.2), 100 mM NaCl, 5 nM fluoresceinated DNA, and 1
g of poly(dI-dC) as non-specific DNA. The protein solution containing 2,500 nM dimeric
Rv0678 or Rv0678 mutant and 5 nM fluoresceinated DNA was titrated into the DNA binding
solution until the millipolarization (mP) become unchanged.  All measurements were
performed at 25oC using a PerkinElmer LS55 spectrofluorometer equipped with a Hamamatsu
R928 photomultiplier. The excitation wavelength was 490 nm, and the fluorescence
polarization signal (in P) was measured at 525 nm.  Each titration point recorded was an
average of 15 measurements.  Data were analyzed using the equation, P = {(Pbound –
Pfree)[protein]/(KD + [protein])} + Pfree, where P is the polarization measured at a given total
protein concentration, Pfree is the initial polarization of free fluorescein-labeled DNA, Pbound is
the maximum polarization of specifically bound DNA, and [protein] is the protein
concentration.  The titration experiments were repeated for three times to obtained the average
KD value.  Curve fitting was accomplished using the program ORIGIN (OriginLab
Corporation, Northampton, MA).
Results and discussion
Overall structure of Rv0678
M. tuberculosis Rv0678 belongs to the MarR family of regulators.  It possesses 165
amino acids, sharing 14% and 15% protein sequence identity with MarR (22) and OhrR (36)
(Fig. 1).  The crystal structure of Rv0678 was determined to a resolution of 1.64 Å using single
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isomorphous replacement with anomalous scattering (SIRAS) (Table 1).  Four molecules of
Rv0678 are found in the asymmetric unit, which assemble as two independent dimers (Fig. 2).
Superimposition of these two dimers gives an RMSD of 0.8 Å over 271 C atoms, indicating
that their conformations are nearly identical to each other.
The structure of Rv0678 (Fig. 3) is quite distinct in comparison with the known
structures of the MarR-family regulators (22, 36-39).  Each subunit of Rv0678 is composed of
six α-helices and two β-strands: 1 (17-31), 2 (36-47), 3 (55-62), 4 (66-79), 1 (82-85),
2 (94-97), 5 (101-127) and 6 (132-160) (Fig. 1).  The monomer is L-shaped with the shorter
side forming a DNA-binding domain.  However, the longer side contributes to an extended
long arm, creating a dimerization domain for the regulator.  Residues 34-99, which include 2,
3, 4, 1 and 2, are responsible for constructing the DNA-binding domain. The
dimerization domain of Rv0678 is generated by residues 16-32 and 101-160, which cover 1,
5 and 6 of the protomer.  Each protomer of Rv0678 is approximately 55 Å tall, 35 Å wide
and 35 Å thick.
As a member of the MarR family of regulators, the DNA-binding domain of Rv0678
features a typical winged helix-turn-helix (wHtH) binding motif.  The two anti-parallel 1 and
2 strands are found to generate a -hairpin structure, which also forms the wing of the DNA-
binding domain.  The crystal structure of the OhrR-DNA complex (36) showed that this -
hairpin directly participates to contact the double-stranded DNA and is critical for repressor-
operator interactions.  Another important component of the wHtH motif for DNA recognition
is helix 4.  In the OhrR-DNA complex (36), the corresponding -helix is found to bind within
the deep major groove of the B-DNA. Protein sequence alignment suggests that Rv0678
contains three conserved amino acids common among members of the MarR family.  These
three residues, R84, D90 and R92, are located within the DNA-binding domain of the regulator
(Fig. 1), and are likely important for protein-DNA interactions.  Among them, D90 and R92
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are positioned within the -hairpin of the wing.  The corresponding amino acids located at the
winged loop region of the ST1710 regulator play a major role in regulator-promoter
interactions (39).
The Rv0678 crystal structure reveals that helices 1, 5 and 6 are involved in the
formation of the dimer.  Specifically, helices 5, 6, 5 and 6 (where the prime denotes the
next subunit) form intertwined helical bundles and constitute the dimerization domain.  Helices
6 and 6 are oriented in an anti-parallel fashion and form the scaffold of the dimer (Fig. 3).
Extensive hydrophobic interactions are observed at the interface between the two subunits of
the regulator.  In addition, Y147 and Y159 and their identical counter pair perform aromatic
stacking interactions, securing the dimeric organization.  Additional salt bridges between R32
and E115 and between E106 and R109 (as well as their counter pairs) stabilize the binding.
Perhaps the most striking difference between the structures of Rv0678 and other MarR-
family members is the relative orientation of the DNA-binding and dimerization domains.  The
structures of MarR (22), OhrR (36) and MexR (37, 38) suggest that helices 4 and 4 orient
approximately perpendicular to the pseudo two-fold axis of the dimeric regulators.  However,
our crystal structure of Rv0678 depicts these two helices more or less in parallel with the
dimer’s pseudo two-fold axis.  Similar orientation of helix 4 has also been found in the
structure of the Vibrio cholerae AphA transcriptional activator (40). This conformation is not
compatible and does not allow the regulator to interact with the B-form DNA.  To bind its
cognate DNA, the Rv0678 regulator must undergo a large conformational movement that
reorients the DNA-binding domain such that the positions of helices 4 and 4 can be matched
with the two consecutive major groove of the promoter DNA.  Based on the OhrR-DNA (36)
and ST1710-DNA (39) crystal complexes, we predict that the entire DNA-binding domain of
Rv0678, including 2, 3, 4, 1 and 2, has to rotate downward by ~70o with respect to 5
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of the dimerization domain before DNA binding (Fig. 4).  If this is the case, then the loop
region between 2 and 5 form the hinge for this rotational motion.
Rv0678 was liganded
Unexpectedly, a large extra electron density was found at the interface between the
DNA-binding and dimerization domains of Rv0678, indicating the existence of a fortuitous
bound ligand co-purified and co-crystallized with the regulator (Fig. 5).  Thus, this region is
also a substrate-binding site.  To identify the unknown bound ligand, gas chromatography
coupled with mass spectrometry (GC-MS) was applied to investigate the Rv0678 crystals (Fig.
6).  The result suggests that the fortuitous ligand is 2-palmitoylglycerol, also called
octadecanoic acid, 2-hydroxyl-1-(hydroxymethyl)ethyl ester, which contains 21 carbons with
the molecular formula C21H42O4.  That this fatty acid glycerol ester is co-purified with the
Rv0678 regulator suggests that fatty acid glycerol esters may be the natural substrates for this
protein.
The propanetriol of the bound 2-palmitoylglycerol is completely buried within the
dimer interface, leaving the tail portion of its elongated octadecanoate hydrophobic carbon
chain oriented at the entry point of this binding site.  This orientation facilitates the contribution
of R32 and E106 to form two hydrogen bonds with the glycerol head group of the fatty acid.
The backbone oxygen of F79 also participates to create the third hydrogen bond with this
glycerol head group.  In addition, the carbonyl oxygen of the octadecanoate group contributes
to make another hydrogen bond with R109, securing the binding.  Interestingly, Rv0678 further
anchors the bound fatty acid molecule through hydrophobic interactions with residues F79,
F79 and F81.  Therefore, the binding of 2-palmitoylglycerol in Rv0678 is extensive:  Within
4.5 Å of the bound fatty acid glycerol ester, 20 amino acids contact this molecule (Table 4).  It
should be noted that residues F79, F79 and F81 belong to helices 4 and 4.  In the OhrR-
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DNA structure (36), the corresponding 4 and 4 helices were buried within the two
consecutive major grooves, directly contacting the promoter DNA.  Thus, we suspect that
helices 4 and 4 have dual responsibilities in the Rv0678 regulator.  They form the DNA-
binding site for operator DNA as well as substrate-binding site for inducing ligands.
In the second Rv0678 dimer of the asymmetric unit, it is also found that a 2-
palmitoylglycerol molecule is bound within the corresponding substrate-binding site.  Residues
contributed to form this binding site are nearly identical but with a slightly different subset of
amino acids in comparison with those of the first Rv0678 dimer described above (Table 4).
Virtual ligand library screening
Virtual ligand screening was then performed to elucidate the nature of protein-ligand
interactions in the Rv0678 regulator.  The 2-palmitoylglycerol binding site was chosen as a
substrate binding cavity for this docking study. AutoDock Vina (32) was used to screen small
molecules listed in the DrugBank (33) and ZINC (34) libraries.  Vina utilizes the iterated local
search global optimizer algorithm, which results in predicted binding free energies for these
compounds ranging from -13.8 to +20 kcal/mol.  Of the 70,000 screened compounds, it is
predicted that the best substrate for Rv0678 is the heterocyclic compound diethyl-[(5E)-5-
(6,8,9,10-tetrahydro-5H-benzo[c]xanthen-11-ylmethylene)-7,8-dihydro-6H-xanthen-3-yli.
Table 5 lists the top three substrates, which have the lowest predicted binding free energies, for
the Rv0678 regulator.
As the crystal structure of Rv0678 depicts that a fatty acid glycerol ester is bound within
the substrate binding site of this regulator, Vina (32) was also used to examine if these fatty
acids are able to interact with Rv0678.  As a positive control, the molecule 2-palmitoylglycerol
was docked into the substrate-binding site of this regulator, resulting in a predicted binding
free energy of -7.6 kcal/mol.  Vina was then used to screen for 2,500 different fatty acids.
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Based on the lowest predicted binding free energies, the top three compounds in this class was
selected and listed in Table 6, where 18-[8-chloro-1-(hydroxymethyl)-6-phenyl-4H-
[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]octadecanoic acid is the best compound for
Rv0678 binding among these fatty acids.
Rv0678-ligand interaction
The binding affinity of 1-stearoyl-rac-glycerol for the Rv0678 regulator was then
determined using is ITC, which obtained a binding affinity constant, KA, of 4.9 ± 0.4 x 105 M-
1
.  The titration is characterized by a negative enthalpic contribution, which gives rise to a
hyperbolic binding curve (Fig. 7).  The thermodynamic parameters of binding of 1-stearoyl-
rac-glycerol to Rv0678 display enthalpic (∆H) and entropic (∆S) contributions of -1.0 ± 0.1
kcal/mol and 22.5 cal•mol•deg-1, respectively.  Interestingly, the molar ratio for this binding
reaction based on ITC is one Rv0678 dimer per ligand.  This ligand-binding experiment
confirms that Rv0678 is capable of recognizing fatty acid glycerol esters.
Electrophoretic mobility shift assay
To demonstrate direct transcriptional regulation, we performed EMSAs using a probe
corresponding to the intergenic region between mmpS5 and rv0678 (Fig. 8a).  This probe
shifted in a concentration-dependent manner (Fig. 8b).  This result is consistent with previous
reports of altered mmpS5/mmpL5 gene expression in M. bovis BCG spontaneous rv0678
mutants (13).  Preliminary CHIPSeq data from the TB Systems Biology Consortium suggests
Rv0678 regulates expression of additional genes (41).  We designed additional probes to
experimentally demonstrate binding of Rv0678 to the promoter regions of mmpS2-mmpL2,
mmpS4-mmpL4 and rv0991-0992.  Probes are depicted schematically in Fig. 8a.  We also saw
concentration-dependent binding of Rv0678 to these two probes (Fig. 8b).  As a control,
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EMSAs were performed in the presence of non-labeled probes.  Release of Dig-labeled probe
was observed consistent with specific binding of Rv0678 to the rv0678-mmpS5, rv0505-
mmpS2 and mmpL4 probes (Fig. 8c).  Using the sequence of the six probes that shifted, we
identified a putative consensus binding sequence for Rv0678 using the MEME algorithm (42)
(Fig. 8e).  Rv0678 co-crystallized with a ligand whose binding renders the protein unable to
bind DNA.  Addition of 1-stearoyl-rac-glycerol (an isomer of 2-palmitoylglycerol) to the
EMSA reaction buffer reduced Rv0678 binding to a target promoter probe (Fig. 8c).
Dye primer based DNase I footprint assay
To further refine the binding site of Rv0678 in the rv0678-mmpS5 intergenic region,
DNase I footprint assay was performed on the Rv0678-mmpS5 probe using established
methods (35). Electropherograms in Figure 9 show the DNA sequence bound by Rv0678. The
control protein BSA did not result in DNA protection at the same concentration. Interestingly,
the region bound by Rv0678 includes the start codon of the rv0678 gene (underlined
nucleotides, Fig. 9b). The bound sequence contains a potential inverted repeat motif
(GAACGTCACAGATTTCA … N8 … TGAAACTTGTGAGCGTCAAC).
Rv0678-DNA interaction
Fluorescence polarization-based assay was carried out to study the interaction between
Rv0678 and the 26-bp DNA containing the 18-bp putative promoter DNA sequence
(TTTCAGAGTACAGTGAAA).  Our footprint assay has suggested that this promoter DNA
sequence was protected by the Rv0678 regulator.  Fig. 10a illustrates the binding isotherm of
Rv0678 in the presence of 5 nM fluoresceinated DNA.  The titration experiment indicated that
this regulator binds the 26-bp promoter DNA with a dissociation constant, KD, of 19.6  3.0
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nM.  The binding data also indicate that Rv0678 binds its cognate DNA with a stoichiometry
of one Rv0678 dimer per ds-DNA.
In addition, fluorescence polarization was used to determine the binding affinities of
this 26-bp DNA by the Rv0678 mutants D90A and R92A.  These two residues are located
within the -hairpin of the wHtH motif of the N-terminal DNA-binding domain.  In ST1710,
the corresponding two residues are critical for regulator-promoter interactions. Interestingly,
our measurements indicate that the KD values of the D90A-DNA and R92A-DNA complexes
are 113.3  16.8 and 86.0  7.4 nM (Fig. 10b and c), revealing the DNA binding affinities for
these mutants are significantly weaker than that of the native Rv0678 regulator.  Like ST1710,
our experimental results suggest that residues D90 and R92 are important for DNA recognition.
With the rising incidence of drug resistant strains of M. tuberculosis, it is increasingly
important to understand the molecular mechanisms underlying virulence and drug resistance
of this pathogen.  This knowledge will inform the development of new strategies to combat
TB.  In this report, we describe the crystal structure the Rv0678 transcriptional regulator, which
controls the expression level of the MmpS5-MmpL5, MmpS4-MmpL4 and MmpS2-MmpL2
transport systems.  MmpS4 and MmpS5 contribute to siderophore export, but the substrate of
MmpL2 is not known (15). Fortuitously, the structure of Rv0678 was resolved in complex with
a 2-palmitoylglycerol molecule, suggesting that fatty acid glycerol esters are the natural
substrates for the Rv0678 transcriptional regulator.  Further work is required to demonstrate if
this ligand is structurally related to the substrate of either efflux system, or how its availability
changes in different environments and mycobacterial growth phases. The crystal structure of
the 2-palmitoylglycerol-Rv0678 complex probably provides a snapshot of the ligand-binding
state of this regulator, whereby both the DNA-binding and dimerization domains are recruited
to participate for ligand binding.  In this case, the DNA-binding domain must bend upward and
shift towards the dimerization domain to accommodate the bound ligand.  As crystallized, the
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regulator is incompatible with the operator DNA.  When the inducing ligand is removed from
the ligand-binding site, freeing helices 4 and 4 to rotate downward and shift away from the
dimerization domain, this conformational state should be compatible with the B-DNA and
allow for DNA binding.
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Figures and captions
Figure 1. Protein sequence alignment of the MarR family of regulators.  Alignment of the
amino acid sequences of Mycobacterium tuberculosis Rv0678, Bacillus subtilis OhrR,
Pseudomonas aeruginosa MexR, Escherichia coli MarR and Sulfolobus tokodaii ST1710.
The alignment is done using FFAS03.  The topology of M. tuberculosis Rv0678 is shown at
the top.  The three conserved amino acids are highlighted with yellow bars.
Rv0678 11 GAEPDIMEFVEQMGGYFESRSLTRLAG--RLLGWLLVCDPERQSSEELATALAASSG 65OhrR 17 LLYASSREMTKQYKPLLDKLNIT----YPQYLALLLLWEHETLTVKKMGEQLYLDSG 69MexR 13 –LMAVFQHVRTRIQSELDCQRLDLTPP--DVHVLKLIDEQRGLNLQDLGRQMCRDKA 66
MarR 18 –IHMVNQKKDRLLNEYLSPLDITAAQF--KVLCSIR--CAACITPVELKKVLSVDLG 69
ST1710 14 TIAKIYRAMSRELNRRLGELNLSYLDF--LVLRAT---SDGPKTMAYLANRYFVTQS 65
Rv0678 66 GISTNARMLIQFGFIERLAVAGDRRTYFRLRPNAFAAGERERIRAMAELQDLADVGL 122
OhrR 70 TLTPMLKRMEQQGLITRKRSEEDERSVLISLTEDGALLKEKAVDIPGTILGLSKQSG 126
MexR 67 LITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELFAPL 123
MarR 70 ALTRMLDRLVCKGWVERLPNPNDKRGVLVKLTTGGAAICEQCHQLVGQDLH--QELT 124
ST1710 66 AITASVDKLEEMGLVVRVRDREDRRKILIEITEKGLETFNKGIEIYKKLANEVTGDL 122
Rv0678 123 RALGDAPPQRSRRLREMRDLLAYMENVVSDALGRYSQRTGEDD 165OhrR 127 EDLKQLKSALYTLLETLHQKN 147
MexR 124 T--PVEQATLVHLLDQCLAAQPLEDI 147
MarR 125 KNLTADEVATLEYLLKKVLP 144
ST1710 123 SE---------DEVILVLDKISKILKRIEEISQ 146
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Figure 2. Stereo view of the experimental electron density maps of Rv0678 at a resolution of
1.64 Å.  (a) The electron density maps are contoured at 1.2 .  The C traces of the two
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Rv0678 dimers in the asymmetric unit are in yellow, light blue, tv red and lime green.
Anomalous signals of the six W6(-O)6(-Cl)6Cl62- cluster sites (contoured at 4 ) found in
the asymmetric unit are colored red.  (b) Representative section of electron density in the
vicinity of helices 1 and 2. The solvent-flattened electron density (50-1.64 Å) is contoured
at 1.2  and superimposed with the final refined model (green, carbon; red, oxygen; blue
nitrogen; yellow, sulfur).
39
Figure 3. Structure of the M. tuberculosis Rv0678 regulator.  (a) Ribbon diagram of a
protomer of Rv0678.  The molecule is colored using a rainbow gradient from the N-terminus
(blue) to the C-terminus (red).  (b) Ribbon diagram of the Rv0678 dimer.  Each subunit of
Rv0678 is labeled with a different color (yellow and orange).  The bound 2-palmitoylglycerol
within the dimer is shown in sphere form (gray, carbon; red, oxygen). The figure was
prepared using PyMOL (http://www.pymol.sourceforge.net).
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Figure 4. Rigid-body rotation of the DNA-binding domain of Rv0678.  This is a schematic
representation illustrating the conformational change of Rv0678 between the ligand bound
and unbound structures.  Helices 4 and 4 of the DNA-binding domain are indicated.  The
ligand is colored blue.
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Figure 5. Simulated annealing electron density maps and the 2-palmitoylglycerol binding
site.  (a) Stereo view of the simulated annealing electron density map of the bound 2-
palmitoylglycerol within the Rv0678 dimer (the orientation corresponds to the side view of
Fig. 1b).  The bound 2-palmitoylglycerol is shown as a stick model (green, carbon; red,
oxygen).  The simulated annealing 2Fo-Fc electron density map is contoured at 1.2  (blue
mesh).  The left and right subunits of Rv0678 are shown as orange and yellow ribbons.  (b)
The 2-palmitoylglycerol binding site.  Amino acid residues within 3.9 Å from the bound 2-
palmitoylglycerol (green, carbon; red, oxygen) are included.  The side chains of selected
residues from the right subunit of Rv0678 in Figure 1b are shown as yellow sticks (yellow,
carbon; blue, nitrogen; red, oxygen).  Residues from the next subunit of Rv0678 are shown as
orange sticks (orange, carbon; blue, nitrogen; red, oxygen).  (c) Schematic representation of
the Rv0678 and 2-palmitoylglycerol interactions.  Amino acid residues within 4.5 Å from the
bound 2-palmitoylglycerol are included.  Dotted lines depict the hydrogen bonds.  The
hydrogen-bonded distances are also indicated in this figure.
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Figure 6. Identification of the fortuitous ligand by GC-MS.  (a) Electron ionization (EI)
spectrum of the strongest GC peak at 14.45 min. (b) GC-MS spectrum of octadecanoic acid,
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2-hydroxyl-1-(hydroxymethyl)ethyl ester from the internal GC-MS library. The ligand was
identified as 2-palmitoylglycerol.
Figure 7. Representative isothermal titration calorimetry for the binding of 1-stearoyl-rac-
glycerol to Rv0678.  (a) Each peak corresponds to the injection of 10 l of 400 M dimeric
Rv0678 in buffer containing 10 mM Na-phosphate (pH 7.2), 100 mM NaCl and 0.001%
DDM into the reaction containing 20 M 1-stearoyl-rac-glycerol in the same buffer.  (b)
45
Cumulative heat of reaction is displayed as a function of the injection number.  The solid line
is the least-square fit to the experimental data, giving a KA of 4.9 ± 0.4 x 105 M-1.
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Figure 8. Rv0678 binds to promoter regions of mmpS2-mmpL2, mmpS4-mmpL4, mmpS5 and
rv0991-2c. (a) A schematic depicting the DNA probes used in electrophoretic mobility shift
assays (EMSAs) to examine the promoter and intragenic regions of the mmpS2-mmpL2,
mmpL3, mmpS4-mmpL4, mmpS5-mmpL5 and rv0991-2c genes. (b) EMSAs were performed
using 12 nM Dig-labeled probe and the indicated micromolar concentrations of protein. An
arrow denotes the shifted probes. (c) To demonstrate specificity, EMSAs were performed in
the presence of non-labeled (“cold”) probe. Reactions were performed with 6 nM Dig-labeled
probe, the indicated micromolar concentrations of protein, and 0.6 M cold probe. The
asterisk notes the accumulation of free Dig-labeled probe. (d) EMSAS were performed using
12 M Dig-labeled probe and 6 M Rv0678 in the presence or absence of 1 M 1-stearoyl-
rac-glycerol as indicated above the blot. (e) The sequence of the probes bound by Rv0678 in
panel b and c were compared using the motif-based sequence analysis tool MEME, yielding a
putative Rv0678 binding motif.
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Figure 9. Direct binding of Rv0678 to the rv0678-mmpS5 intergenic region by dye primer
based DNase I footprint assay. Electropherograms indicating the protection pattern of the
Rv0678-mmpS5 probe after digestion with DNase I following incubation with (a) 0, (b) 1
M Rv0678 and (c) 1 M BSA are shown. The protected DNA sequence is indicated above
the electropherogram in panel b, the predicted start codon of rv0678 is underlined.
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Figure 10. Representative fluorescence polarization of Rv0678.  (a) The binding isotherm of
Rv0678 with the 26-bp DNA containing the 18-bp promoter sequence, showing a KD of 19.6
 3.0 nM.  (b) The binding isotherm of mutant D90A with the 26-bp DNA, showing a KD of
49
113.3  16.8 nM.  (c) The binding isotherm of mutant R92A with the 26-bp DNA, showing a
KD of 86.0  7.4 nM.  Fluorescence polarization is defined by the equation, FP = (V – H) / (V
+ H), where FP equals polarization, V equals the vertical component of the emitted light, and
H equals the horizontal component of the emitted light of a fluorophore when excited by
vertical plane polarized light.  FP is a dimensionless entity and is not dependent on the
intensity of the emitted light or on the concentration of the fluorophore.  mP is related to FP,
where 1 mP equals one thousandth of a FP.
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Table 2.  Primers.
Probe Primer 1 Primer 2
Rv0678 CTTCGGAACCAAAGAAAGTG CCAACCGAGTCAAACTCCTG
Rv0505 GAACACGAGGGTGAGGATG GCGTCGTCTCGACCGTGAC
Rv0991-2 GAGCTGGTTGACTTCTCGG CAATGCGGTCGGCGTGGTG
Table 3.  Primers for site-directed mutagenesis.
D90A-forward 5'-CGCCTGGCAGTCGCTGGTGCTCGTCGCACGTATTTTCGTC-3'
D90A-reverse 5'-GACGAAAATACGTGCGACGAGCACCAGCGACTGCCAGGCG-3'
R92A-forward 5'-GCAGTCGCTGGTGATCGTGCCACGTATTTTCGTCTGCGC-3'
R92A-reverse 5'-GCGCAGACGAAAATACGTGGCACGATCACCAGCGACTGC-3'
Table 4.  Rv0678-ligand contacts.
Dimer 1 Dimer 2
Residue-ligand
contacts
Distance (Å) Distance (Å)
R32 3.2* -
Q78 3.9 3.7
F79 3.8 4.2
E108 3.4 3.2
R109 2.8* 3.2*
R111 3.4 3.5
A112 4.0 3.6
M113 - 4.4
E115 3.0 2.9
L116 4.4 3.7
L144 - 4.4
L145 - 4.0
Y28' 4.0 3.9
F29' 4.4 4.3
R32' 3.5 3.6
L34' 4.2 3.6
F79' 2.8* -
F81' 3.4 3.5
F102' 4.5 2.3
A103' - 4.4
G105' 2.9 3.0
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Table 4. Continued.
E106' 3.2* 3.1*
E108' 3.9 -
R109' 3.8 3.5
* Hydrogen bond distance
Contacts within 4.5Å are listed
Table 5.  Top three ligands for the Rv0678 regulator.
Ligand Structure of ligand Binding affinity
(kcal/mol)
Diethyl-[(5E)-5-(6,8,9,10-
tetrahydro-5H-benzo[c]xanthen-11-
ylmethylene)-7,8-dihydro-6H-
xanthen-3-yli
O
O+
N
-13.8
(5E)-N,N-diethyl-5-(6,8,9,10-
tetrahydrochromeno[3,2-c]chromen-
11-ylmethylene)-7,8-dihydro-6H-
xanthen
-13.5
Dibenzylfluorescein -13.4
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Table 6.  Top three fatty acids for the Rv0678 regulator.
Fatty acid Structure of fatty acid Binding
affinity
(kcal/mol)
18-[8-chloro-1-
(hydroxymethyl)-6-phenyl-4H-
[1,2,4]triazolo[4,3-
a][1,4]benzodiazepin-4-
yl]octadecanoic acid
-10.6
2-[2-oxo-2-[4-[2-(1-
phenyltetrazol-5-
yl)sulfanylacetyl]anilino]ethyl]
octadecanoic acid
-10.5
12-(anthracene-1-
carbonyl)octadecanoic acid
-10.4
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Abstract
As one of the world’s most prevalent enteric pathogens, Campylobaceter jejuni is a
major causative agent of human enterocolitis and is responsible for more than 400 million
cases of diarrhea each year.  The impact of this pathogen on children is of particular
significance. Campylobacter has developed resistance to many antimicrobial agents via
multidrug efflux machinery.  The CmeABC tripartite multidrug efflux pump, belonging to
the resistance-nodulation-cell division (RND) superfamily, plays a major role in drug
resistant phenotypes of C. jejuni.  This efflux complex spans the entire cell envelop of C.
jejuni and mediates resistance to various antibiotics and toxic compounds. We here report
the crystal structure of C. jejuni CmeC, the outer membrane component of the CmeABC
tripartite multidrug efflux system. The structure reveals a possible mechanism for substrate
export.
Introduction
Campylobacter jejuni is a major causative agent of human enterocolitis and is
responsible for more than 400 million cases of diarrhea each year worldwide.1
Campylobacter infection may also trigger an autoimmune response, which is associated with
the development of Guillain-Barre syndrome, an acute flaccid paralysis caused by
degeneration of the peripheral nervous system.2 C. jejuni is widely distributed in the
intestinal tracts of animals and is transmitted to humans via contaminated food, water, or raw
milk.  For antibiotic treatment of human campylobacteriosis, fluoroquinolones and
macrolides are frequently prescribed.  Unfortunately, Campylobacter has developed
resistance to these antimicrobials, especially fluoroquinolones.3-5 Antimicrobial resistance in
Campylobacter has become a major concern for public health.  Resistance of Campylobacter
to antibiotics is mediated by multiple mechanisms,6 including synthesis of antibiotic-
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inactivating enzymes, alteration or protection of antibiotic targets and active extrusion of
drugs from Campylobacter cells via multidrug efflux pumps.  While the first two
mechanisms typically confer resistance to a specific class of drugs, multidrug efflux pumps in
Campylobacter contribute to both intrinsic and acquired resistance to a broad range of
antimicrobials and toxic compounds.  Acquisition of antibiotic resistance by Campylobacter
not only compromises the effectiveness of clinical treatment, but also affect the course of the
clinical diseases.
According to the genomic sequence of NCTC 11168, C. jejuni harbors 13 putative
antibiotic efflux transporters of the resistance-nodulation-cell division (RND), ATP-binding
cassette (ABC), multidrug and toxic compound extrusion (MATE), major facilitator (MF)
and small multidrug resistance (SMR) families.7 In Gram-negative pathogens, efflux systems
belonging to the hydrophobic and amphiphilic efflux RND (HAE-RND) play major roles in
the intrinsic and acquired tolerance of antibiotics and toxic compounds. Among them, the
Campylobacter multidrug efflux system CmeABC,8-10 a HAE-RND-type efflux pump,11 is
the primary antibiotic efflux system and is the best functionally characterized transporter in
Campylobacter.  The tripartite CmeABC complex includes the outer membrane channel
CmeC, the inner membrane drug transporter CmeB, and the periplasmic membrane fusion
protein CmeA.  CmeABC contributes significantly to the intrinsic and acquired resistance of
Campylobacter to structurally diverse antimicrobials, including fluoroquinolones and
macrolides, by reducing the accumulation of drugs in Campylobacter cells.8,10,12 It has been
found that CmeABC functions synergistically with target mutations in conferring and
maintaining high-level resistance to fluoroquinolones and macrolides.12,13 This efflux pump
also plays an important role in the emergence of fluoroquinolone-resistant Campylobacter
under selection pressure.14 Inactivation of CmeABC reduced the frequency of emergence of
fluoroquinolone-resistant mutants, while overexpression of CmeABC increased this
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frequency.14 The contributing effect of CmeABC is attributed to the fact that many of the
spontaneous gyrA mutants cannot survive the selection by ciprofloxacin in the absence of
CmeABC.
In addition to conferring antibiotic resistance, CmeABC has an important role in bile
resistance.  As an enteric pathogen, C. jejuni must possess means to adapt in the animal
intestinal tract, where bile acids are commonly present.  Indeed, it has been suggested that
bile resistance is the natural function of this HAE-RND-type efflux pump.9
Currently, two crystal structures of the HAE-RND efflux pumps have been resolved
by crystallography. These efflux pumps are the Escherichia coli AcrB15-20 and Pseudomonas
aeruginosa MexB21 multidrug transporters.  The crystal structures of other components of
these tripartite complex systems have also been determined.  These include the outer
membrane channels, E. coli TolC22 and P. aeruginosa OprM,23 as well as the periplasmic
membrane fusion proteins, E. coli AcrA24 and P. aeruginosa MexA.25-27
Thus far, no structural information is available for any protein component of the
CmeABC tripartite complex system.   To elucidate the mechanism used by the C. jejuni
CmeABC efflux system for multidrug extrusion, we here describe the crystal structure of the
CmeC outer membrane channel.  The structure reveals that this the interior surface of this
channel is closed at the outer membrane surface as well as the periplasmic tip, raising the
possibility that this channel forms two gates for substrate export.
Results and discussion
Overall structure of the C. jejuni CmeC outer membrane channel
We cloned, expressed, purified and crystallized the full-length CmeC channel protein
that contains a 6xHis tag at the C-terminus. We obtained crystals of this membrane protein
using vapor diffusion. Data collection and refinement statistics are summarized in Table 1.
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The diffraction data were indexed to the space group C2221.  The crystal structure of CmeC
was then determined to a resolution of 2.37 Å using single anomalous dispersion.  In the
asymmetric unit, three CmeC protomers were found to form a trimer.  Figure 1 illustrates the
electron density maps of this CmeC trimer.  The final structure consists of 100% of the
protein sequence, and is refined to Rwork and Rfree of 21.0% and 24.3%, respectively (Table
1).
CmeC assembles as a trimer of 492 residues per protomer.  Like other known
structures of outer membrane channel proteins, including TolC22 and OprM,23 the appearance
of the CmeC trimer is that of a cannon, forming a 130 Å long tunnel to export antimicrobials
such as fluoroquinolones and macrolides.  Each monomer contributes four -strands and six
-helices to form the transmembrane -barrel and periplasmic -helical domains (Figs. 2 and
3).  In addition, the CmeC trimer contains an equatorial domain, which is made up of 12 short
-helices (four from each protomer), encircling the mid-section of the periplasmic -helical
domain.  The periplasmic tunnel of CmeC is nearly 100 Å long with an outermost diameter of
35 Å at the tip of the tunnel.
Like other outer membrane channel protein structures, including TolC,22 OprM23 and
CusC,28,29 CmeC possesses a typical charge distribution found in this protein family.  That is,
the interior surface of the CmeC channel is strikingly electronegative (Fig. 4).  However, the
charge distribution of the exterior surface of a typical outer membrane channel is quite
random and does not form extensive positively or negatively charge patches.  CmeC is
distinct in that its exterior surface is also predominately occupied by acidic residues (Fig. 4).
The N-terminal cysteine residue
It is interesting to note that the N-terminal end of CmeC forms an elongated loop.
This loop extends from the membrane surface and leads down to the equatorial domain in the
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periplasm (Fig. 2).  The first N-terminal residue of CmeC is a cysteine.  Like OprM23 and
CusC,28 the crystal structure of CmeC suggests that this residue is covalently linked to the
lipid elements at the inner leaflet of the outer membrane.  This cysteine residue is believed to
play an important role in protein-membrane interaction and critical for the insertion of this
channel protein into the outer membrane.29 It has been shown that a single-point mutation on
the corresponding cysteine residue in the CusC channel is able to unfold the entire
transmembrane -barrels, disallowing the channel protein to anchor to the outer membrane.29
As phylogenetic tree of homologous suggests that C. jejuni CmeC and E. coli CusC are
derived from the same branch, it is expected that a mutation on this N-terminal cysteine
residue will have a drastic effect on the structure and function of the CmeC channel.
CmeC forms two interior gates
The structure of CmeC indicates that this channel is at its closed conformational state
as this channel is closed at both ends.  The interior of the CmeC outer membrane -barrel is
partially occluded (Fig. 5).  Residues 96-108 appear to form a flexible loop between strands
S3 and S4.  This loop may be responsible for the opening and closing of the top end of the -
barrel.  In the CmeC structure, the three R104 residues from different protomers are found to
interact with each other through hydrogen bonds (Fig. 6).  Thus, R104 seems to form a gate
at the upper part of the -barrel and control the passage of antimicrobial molecules through
the outer membrane.
The periplasmic end of the -barrel of CmeC is also partially occluded (Fig. 5).  The
-helices at this end, inner H7/H8 and outer H3/H4, are densely packed through coiled-coil
interactions.  The gate is formed by a layer of charged and polar residues, including Q412,
D413, E416 and N420 (Fig. 6).  Among these residues, Q412 and E416 of the next subunit
interact through hydrogen bonds to form the gate’s central core.  Thus, the CmeC channel
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protein seems to form two gates: a negatively charged gate located at the tip of the -helical
periplasmic domain, and a positively charged gate found at the top portion of the interior of
the -barrel outer membrane domain.  During antimicrobial extrusion, these two gates may
dilate sequentially to allow passage of these antimicrobial molecules.
The exterior intra- and inter-protomer grooves
The outermost surface of the periplasmic domain of the CmeC trimer forms three
intra-protomer and three inter-protomer grooves.  Like the MtrE channel,30,31 these CmeC
grooves are likely to provide interaction sites for the CmeA membrane fusion protein.  If this
is the case, then the -helical coiled-coil domain of the CmeA fusion protein is likely to fit
into these grooves and contact CmeC to form a complex to function.  In turn, this CmeA-
CmeC interaction could control the opening and closing of the CmeC outer membrane
channel, similar to the case of the Neisseria gonorrhoeae MtrCDE efflux system.30,31
It is well established that overexpression of RND multidrug efflux pumps leads to a
resistant phenotype in pathogenic organisms.  Because of the fact that these multidrug efflux
pumps are able to respond to a wide spectrum of substrates, pathogenic bacteria that
overexpress them can be selected for by many different agents.32 Thus, it is very important to
understand the molecular mechanism as well as detailed structural information of these efflux
pumps in order to combat infectious diseases. The pathogen Campylobacter has developed
resistance to many antimicrobial agents.  The availability of the crystal structure of the CmeC
outer membrane channel may allow us to rationally design agents that block the function of
this channel protein and eventually heighten the sensitivity of this pathogen to antimicrobials.
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Materials and methods
Cloning, expression and purification of the outer membrane CmeC channel
The full-length CmeC membrane protein containing a 6xHis tag at the C-terminus
was overproduced in E. coli C43(DE3)/pBAD22bcmeC cells.  Cells were grown in 12 L of
LB medium with 100 g/ml ampicillin at 37oC.  When the OD600 reached 0.5, the culture was
cooled down to 25oC and then treated with 0.2% arabinose to induce cmeC expression.  Cells
were harvested after shaking for 16 h at 25oC.  The collected bacteria were resuspended in
buffer containing 20 mM Na-HEPES (pH 7.5), 300 mM NaCl and 1 mM
phenylmethanesulfonyl fluoride (PMSF), and then disrupted with a French pressure cell.  The
membrane fraction was collected by ultracentrifugation, followed by a pre-extraction
procedure by incubating in buffer containing 0.5% sodium lauroyl sarcosinate, 20 mM Na-
HEPES (pH 7.5) and 50 mM NaCl for 0.5 h at room temperature.  The membrane was
collected and washed twice with buffer containing 20 mM HEPES-NaOH (pH 7.5) and 50
mM NaCl.  The membrane protein was then solubilized in 2 % (w/v) n-dodecyl -D-
maltoside (DDM).  Insoluble material was removed by ultracentrifugation at 100,000 x g.
The extracted protein was purified with a Ni2+-affinity column.  The purity of the CmeC
protein (>95%) was judged using 12% SDS-PAGE stained with Coomassie Brilliant Blue.
The purified protein was then dialyzed and concentrated to 15 mg/ml in buffer containing 20
mM Na-HEPES (pH 7.5), 200 mM NaCl and 0.05% DDM.
For 6xHis selenomethionyl-substituted (SeMet)-CmeC, the protein was expressed in
E. coli C43(DE3) cells possessing pBAD22bcmeC.  In brief, a 10 ml LB broth overnight
culture containing E. coli C43(DE3)/pBAD22bcmeC cells was transferred into 120 ml of
LB broth containing 100 g/ml ampicillin and grown at 37oC.  When the OD600 value reached
1.2, cells were harvested by centrifugation at 6000 rev/min for 10 min, and then washed two
times with 20 ml of M9 minimal salts solution.  The cells were re-suspended in 120 ml of M9
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media and then transferred into a 12 L pre-warmed M9 solution containing 100 µg/ml
ampicillin.  The cell culture was incubated at 37oC with shaking. When the OD600 reached
0.4, the culture was cooled down to 25oC and 100 mg/l of lysine, phenylalanine and
threonine, 50 mg/l isoleucine, leucine and valine, and 60 mg/l of L-selenomethionine were
added.  The culture was induced with 0.2% arabinose after 15 min.  Cells were then harvested
within 16 h after induction.  Further procedures for the preparation, pre-extraction and
purification of the outer membrane fraction as well as purification of the SeMet-CmeC
protein were identical to those for the native CmeC channel.  The purity of the SeMet-CmeC
protein (>95%) was judged using 10% SDS-PAGE stained with Coomassie Brilliant Blue.
The purified protein was then dialyzed and concentrated to 15 mg/ml in buffer containing 20
mM Na-HEPES (pH 7.5), 200 mM NaCl and 0.05% DDM.
Crystallization of CmeC
Crystals of the 6xHis CmeC were obtained using sitting-drop vapor diffusion.  The
CmeC crystals were grown at room temperature in 24-well plates with the following
procedures.  A 2 l protein solution containing 15 mg/ml CmeC protein in 20 mM Na-
HEPES (pH 7.5), 200 mM NaCl and 0.05% (w/v) DDM was mixed with a 2 l of reservoir
solution containing 18% PEG 400, 0.1 M sodium acetate (pH 4.0), 0.3 M (NH4)2SO4 and 2%
tetraethylene glycol monooctyl ether (C8E4).  The resultant mixture was equilibrated against
500 l of the reservoir solution.  Crystals of CmeC grew to a full size in the drops within two
weeks.  Typically, the dimensions of the crystals were 0.2 mm x 0.2 mm x 0.2 mm.
Cryoprotection was achieved by raising the PEG 400 concentration stepwise to 30% with a
4% increment in each step.  The procedures for growing and preparing the SeMet-CmeC
crystals were identical to those for the native CmeC crystals.
63
Data collection, structural determination and refinement
All diffraction data were collected at 100K at beamline 24ID-C located at the
Advanced Photon Source, using an ADSC Quantum 315 CCD-based detector.  Diffraction
data were processed using DENZO and scaled using SCALEPACK.33
Crystals of the CmeC outer membrane channel belong to the space group C2221
(Table 1).  Based on the molecular weight of CmeC (54.26 kDa), three molecules per
asymmetric unit with a solvent content of 80.6% were expected.  While the structure of
CmeC could be determined using molecular replacement, the structure resulted in a relatively
high refinement R-factor of 49.8%.  To aid modeling of the conformation of CmeC in the
least biased manner, single anomalous dispersion phasing using the program PHASER34 was
employed to obtain experimental phases in addition to the phases from the structural model
of OprM.23 Phases were then subjected to density modification and phase extension to 2.37
Å-resolution using the program RESOLVE.35 The resulting phases were of excellent quality,
which enabled us to trace the conformation of CmeC using the program COOT.36 The full-
length CmeC protein contains five methionine residues and all of these five selenium sites
per CmeC molecule (15 selenium sites per asymmetric unit) were identified.  The SeMet data
not only augmented the experimental phases, but also helped in tracing the molecules by
anomalous difference Fourier maps where we could ascertain the proper registry of SeMet
residues.  After tracing the initial model manually using the program Coot,36 the model was
refined against the native data at 2.37 Å-resolution using TLS refinement techniques adopting
a single TLS body as implemented in PHENIX37 leaving 5% of reflections in Free-R set.
Iterations of refinement using PHENIX37 and CNS38 and model building in Coot36 lead to the
current CmeC model, which consists of 1,419 residues in the asymmetric unit with excellent
geometrical characteristics (Table 1).
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Accession codes
Atomic coordinates and structure factors have been deposited in the Protein Data
Bank under the accession code 4MT4.
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Figures and captions
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Fig. 1.  Stereo view of the experimental electron density map of the CmeC channel at a
resolution of 2.37 Å.  (a) Anomalous maps of the 15 selenium sites (contoured at 4 ).  The
selenium sites corresponding to the four methionines from each protomer of the CmeC trimer
are in orange.  The C traces of CmeC are in green, magenta and white, respectively.  (b)
Representative section of the electron density at the interface between H8 and H9 of the
periplasmic domain of CmeC.  The electron density (colored white) is contoured at the 1.2 
level and superimposed with the final refined model (green, carbon; red, oxygen; blue,
nitrogen).
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Fig. 2.  Structure of the C. jejuni CmeC channel protein. (a) Ribbon diagram of a protomer
of CmeC viewed in the membrane plane.  The molecule is colored using a rainbow gradient
from the N-terminus (blue) to the C-terminus (red).  (b) Ribbon diagram of the CmeC trimer
viewed in the membrane plane.  Each subunit of CmeC is labeled with a different color.  The
CmeC protomer is acylated (in sticks) through the first N-terminal cysteine residue to anchor
onto the outer membrane.
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Fig. 3.  Secondary structural topology of the CmeC monomer.  The topology was constructed
based on the crystal structure of CmeC.  The -helices and -strands are colored orange and
green, respectively.
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Fig. 4.  Electrostatic surface potentials of CmeC.  Surface representations of the (a) outside
and (b) inside the CmeC channel colored by charge (red; negative -15 kT/e, blue; positive
+15 kT/e).
75
Fig. 5.  Surface representations of the trimeric CmeC channel.  The views from both the (a)
extracellular and (b) periplasmic sides suggest that the CmeC channel is in its closed form.
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Fig. 6.  The interior of the CmeC channel.  (a) Extracellular view of the CmeC trimer.  The
three R104 residues of the trimer are found to interact and block the channel.  (b) Periplasmic
view of the CmeC trimer.  The charged and polar residues Q412, D413, E416 and N420 are
found to interact with each other and block this end of the channel.
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Table 1. Data collection, phasing and refinement statistics of CmeC.
Data set CmeC
SeMet-CmeC
(peak)
Data Collection
Wavelength (Å) 0.98 0.98
Space group C2221 C2221
Resolution (Å) 50 – 2.37 50 – 3.10
(2.46-2.37) (3.21-3.10)
Cell constants (Å)
a 92.38 91.95
b 147.35 147.20
c 420.43 419.13
α, β, γ (°) 90, 90, 90 90, 90, 90
Molecules in ASU 3 3
Redundancy 3.3 (3.0) 3.0 (3.0)
Total reflections 2911,371 1203,938
Unique reflections 112,815 51,984
Completeness (%) 97.7 (93.6) 90.7 (83.4)
Rsym (%) 10.9 (42.8) 10.5 (44.9)
I / σ(I) 12.8 (1.3) 12.9 (2.3)
Phasing
Number of sites 15
Figure of merit (acentric/centric) 0.75/0.62
Refinement
Resolution (Å) 50-2.37
Rwork 20.97
Rfree 24.32
rms deviation from ideal
bond lengths (Å) 0.002
bond angles (°) 0.492
Ramachandran plot
most favoured (%) 95.7
additional allowed (%) 4.3
generously allowed (%) 0
disallowed (%) 0
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Introduction
Nitrogen is one of the essential elements for cell metabolism in all the living matter.
The major sources of nitrogen for photosynthetic organisms such as green algae and plants are
nitrate and ammonium which are found abundantly in soil and surface of the ocean. The uptake
and conversion of nitrate found in minerals to organic nitrogen containing compound inside
the cell plays a huge role in sustaining life on earth. The nitrate assimilation in photosynthetic
eukaryotes undergo five successive stages. Nitrate is transported into the cell by plasma
membrane nitrate transporters, then a cytosolic enzyme Nitrate Reductase (NR) reduces nitrate
to nitrite. Subsequently, plastidic nitrite transporters permit the entry of nitrite into the
chloroplast, where the Nitrite Reductase (NiR) enzyme catalyzes the reduction of nitrite to
ammonium [1, 2, 3]. Ultimately, ammonium is incorporated into the carbon framework through
the glutamine synthase/glutamine oxoglutarate transferase or glutamate synthase
(GS/GOGAT) cycle [4, 5].
In the photosynthetic green algae Chlamydomonas reinhardtii, three families of
transporters NRT1, NRT2 and NAR1, are known to take part in nitrate assimilation [2, 3, 6, 7,
8, 9, 10]. A unique NRT1 transporter belong to NRT1/PTR family also called NPF [11] can
been found in C. reinhardtii genome [2]. The NRT2 genes can be found in plants, algae, fungi,
yeast and bacteria [7, 8, 13, 14]. The NRT2 transporters are members of Nitrate Nitrite Porter
(NNP) family which belongs to MFS superfamily [10, 12] and have been marked as high
affinity nitrate/nitrite transporters (HANNiT). Some of the NRT2 transporters require
additional component NAR2 to be fully functional [8]. Both NRT1 and NRT2 proteins are
located at plasma membrane [3, 8, 10].
C. reinhardtii genome encodes six genes in NAR1 family (NAR1.1-NAR1.6) [20, 21].
NAR1.1, NAR1.2 and NAR1.5 possess putative chloroplast transit peptides which indicate a
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possible involvement in nitrite transport to chloroplast [21]. The NAR1 proteins correspond to
Formate/Nitrate Transporter (FNT) family which has been extensively identified in bacterial
genomes. The structural and functional studies of bacterial homologs have shown that FNT-
like proteins are capable of transporting various anions [15, 16, 17, 18, 19]. But their structure
and function are not extensively studied in eukaryotes. Nar1.1 was found clustered with other
genes which are essential to nitrate assimilation and controlled by the nitrate-specific
regulatory gene Nit2 [22]. The previous studies have shown the expression of NAR1.1 was
nitrate induced and ammonium repressed [21]. Studies also have revealed that NAR1.1 is
located at chloroplast envelope and is permeable to nitrite [22]. Moreover, it is suggested that
lack of the NAR1.1 leads to a metabolic imbalance of nitrate incorporation to the chloroplast
[23]. NAR1.2, however, is a chloroplast bicarbonate transporter which plays an important role
in CO2-concentrating mechanism (CCM) in C. reinhardtii. NAR1.2, or limiting CO2 inducible
A (LCIA) allow the movement of bicarbonate into chloroplast envelope under very low CO2
[24, 25]. As for NAR1.5, a plastidic or mitochondrial transit peptide was predicted but the
actual localization is still unknown. The expression of NAR1.5 did not exhibit a sustained
response to nitrogen or carbon sources but showed a nitrate-dependent up-regulation [21]. Here
we report the crystal structures of plastidic nitrite transporters NAR1.1 and NAR1.5 to a
resolution of 2.4 Å and 3.3 Å respectively. In-vitro light scattering experiments have revealed
that both NAR1.1 and NAR1.5 conduct nitrite ions and have identified important residues
playing key roles in nitrite recognition and transport.
Results and discussion
Structure of NAR1.5
Nar1.5 gene of the Nar1 multigene family of Chlamydomonas reinhardtii encodes for
a protein with 343 amino acid residues. Residues 1-78 of NAR1.5 were identified to form a
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transit peptide and were removed before making the recombinant protein construct. After the
removal of the transit peptide forming residues the NAR1.5 was expressed in E. coli and was
purified and crystallized in two space groups, P21 and C2. NAR1.5 crystals diffracted to a
resolution of 3.6 Å in P21 space group and 3.2 Å in C2 (Table S1). The structure in P21 was
solved by molecular replacement accompanied by the single-wavelength anomalous
dispersion (SAD) (Figure S1a, S1b). The structure in C2 was also determined based on the
P21 structure and led to the final model at 3.2 Å (Figure S1c). The asymmetric unit of
NAR1.5 has five molecules organized to form a homopentamer (Figure S1a). The
homopentamer of NAR1.5 reveals a pentagonal cylindrical structure (Figure 1a, 1b) with a
dimension about 80 Å in diameter and 47 Å in height. A wineglass-like pore is located at the
center of the cylinder with 8.0 Å radius at the widest region and 2.5 Å at the narrowest region
close to the stromal side (Figure 1a). The central pore is surrounded by hydrophobic residues
which is in agreement with the structure of stFocA and stNirC, indicating that substrate
transport through this pore is unlikely. The charge distribution on the water accessible
surfaces of NAR1.5 is highly positive at the center of each protomer which is observed in all
the FNT family structures whose structures are available in PDB (Figure 1c, 1d). However, in
contrast to stFocA which possess a highly charged periplasmic and cytoplasmic surface,
NAR1.5 has neutral periplasmic and cytoplasmic surfaces hinting at a distinct functional role
and transporting mechanism. NAR1.5 pentamer is formed by five identical residues with a
pairwise r.m.s.d. of 0.73 Å -0.85 Å. There are ten α-helical segments in each monomer and
eight of them contribute to form six transmembrane helices (TMs 1-6); TM1 (104-131), TM2
(140-179), TM3 (184-212), TM4 (233-255), TM5 (260-295) and TM6 (301-331). TM2 and
TM5 are split by loop regions L2 (161-166) and L5 (277-283) into two α-helical segments
TM2a, TM2b and TM5a, TM5b respectively (Figure 2a). There are two short hydrophilic α-
helices α1 (85-100) at the N-terminal and α2 (219-229) between TM3 and TM4. NAR1.5 is
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localized in the chloroplast envelope membrane which separate the organelles of the
chloroplast from the cytoplasm. NAR1.5 folds into the chloroplast membrane in such a way
that the N-terminal and C-terminal ends are on the same side facing the stroma. The other
side faces the cytoplasm. Each monomer of the NAR1.5 homopentamer possesses a channel
that is predominantly hydrophobic (Figure 3d). The polar residues forming the pore are
contributed by L2 and L5 loops. The channel has its entrance in the cytoplasmic side and
extends towards the stromal side and helps in the movement of substrates from the cytoplasm
towards stroma. The channel has a funnel shaped entrance in the cytoplasmic side formed by
hydrophilic residues of L5. The pore forming residues are L129, K144, F151, L155, T159,
L165, T167, G168, L224, K228, V247, V251, F274, V275, H281 and A284. HOLE was used
to calculate the pore diameter along the axial passage (Figure 3f). The pore also has a central
vestibule which is separated from the cytoplasmic and stromal side by two constriction sites;
constriction site-1 (CS1) close to the cytoplasmic side and constriction site (CS2) close to the
stromal side. CS1 is the narrowest region of the channel and is formed by residues F151,
F274 and H281. H281 lies on L5 whereas F151 and F274 are from TM2a and TM5a. These
three residues are highly conserved in FNT family proteins. CS2 is formed by residues L155,
L165 and V251. L165 is a part of L2 while L155 belongs to TM2a and V251 belongs TM4.
The location of L2 and L5 suggests that the residues forming these loops play a key role in
substrate recognition and regulation of their movements. L2 and L5 being flexible means that
their positioning plays a significant role in functioning of NAR1.5 as a channel. The
electrostatic surface potential shows that the inner lining of the channel is highly positive
which augurs well with the fact that the channel transports anions (figure 3e).
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Structure of NAR1.1
Nar1.1, another gene of the Nar1 multigene family of Chlamydomonas reinhardtii
encodes for a protein with 357 amino acid residues. Residues 1-86 of NAR1.1 forms a transit
peptide and was not included for making the recombinant protein construct. After the
removal of the transit peptide forming residues, the proteins shared 50% sequence identity
NAR1.5. We purified and crystallized NAR1.1 after expressing the recombinant protein in E.
coli. The crystals diffracted X-rays to low resolutions in P21212 space group (Table S1).
Subsequently 13 amino acid residues were deleted from the C-terminal of NAR1.1 and the
crystals diffracted to 2.3 Å in P3121 space group. The structure of NAR1.1 was solved by
molecular replacement using the NAR1.5 structure (Figure S2a). Unlike NAR1.5, the
asymmetric unit of NAR1.1 has ten molecules organized as two homopentamers (Figure S2a,
S2b). The homopentamer of NAR1.1 also reveals a pentagonal cylindrical structure with a
dimension about 80 Å in diameter and 47 Å in height (Figure 2b). A wineglass-like pore is
located at the center of the cylinder with 8.0 Å radius at the widest region and 2.4 Å at the
narrowest region near the stromal side. The central pore is surrounded by hydrophobic
residues and is filled with five elongated electron densities which might represent the
hydrophobic chain of β-D-glucopyranoside. These results are in agreement with the structure
of stFocA and stNirC, indicating that substrate transport through this pore is unlikely. Each
monomer of the pentameric NAR1.1 are identical with a pairwise r.m.s.d. of 0.20 Å -0.32 Å.
There are ten α-helical segments in each monomer and eight of them contribute to form six
transmembrane helices; TM1 (112-143), TM2 (148-187), TM3 (192-220), TM4 (241-264),
TM5 (268-303) and TM6 (309-340). TM2 and TM5 are split by loop regions L2 (169-174)
and L5 (285-290) into two α-helical segments (Figure 2a). There are two short hydrophilic α-
helices; α1 (93-109) at the N-terminal and α2 (227-238) between TM3 and TM4. NAR1.1 is
localized in the chloroplast envelope membrane which separate the organelles of the
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chloroplast from the cytoplasm. NAR1.1 folds into the membrane in a way that the N-
terminal and C-terminal ends are on the same side facing the stroma. The other side faces the
cytoplasm. Each monomer has a channel that is predominantly hydrophobic. The polar
residues forming the pore are contributed by L2 and L5 loops. The channel has its entrance in
the cytoplasmic side and extends towards the stromal side and helps in the movement of
substrates from the cytoplasm towards stroma (Figure 3a). The channel has a funnel shaped
entrance in the cytoplasmic side formed by hydrophilic residues of L5. The pore forming
residues are K107, I126, F159, L163, T166, L167, A171, L173, M232, K236, V255, V259,
V279, F282, I283, H289, A292 and F296. HOLE was used to calculate the pore diameter
along the axial passage (Figure 3a, 3b, 3c). The pore also has a central vestibule which is
separated from the cytoplasmic and stromal side by two constriction sites; constriction site-1
(CS1) close to the cytoplasmic side and constriction site (CS2) close to the stromal side. CS1
is the narrowest region of the channel and is formed by residues F159, F282 and H289
(Figure 4b). H289 lies on L5 whereas F159 and F282 are from TM2a and TM5a. These three
residues are highly conserved in FNT family proteins. CS2 is formed by residues L163, L173
and V255. L173 is a part of L2 while L163 belongs to TM2a and V255 belongs TM4. The
location of L2 and L5 suggests that the residues forming these loops play a key role in
substrate recognition and regulation of their movements. L2 and L5 being flexible means that
their positioning plays a significant role in functioning of NAR1.1 as a channel. The
electrostatic surface potential shows that the inner lining of the channel is highly positive
which augurs well with the fact that the channel transports anions (Figure 2c, 2d). The higher
resolution of NAR1.1 allowed us to determine the interatomic distance between the residues
that form the constriction sites.
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Stopped flow light scattering experiments
In-vitro studies using stopped flow light scattering experiments were carried out on
proteoliposomes to elucidate the substrate transport mechanism of NAR1.1 and NAR1.5.
Previous studies suggest that both these proteins are involved in nitrite (NO2-) assimilation
and regulation. Our results have shown that wild type of both NAR1.1 and NAR1.5 transport
NO2- (Figure 5a). We have also identified three possible gating regions in NAR1.1 monomer.
Two of these gating regions are salt triads formed by Lys-Glu-Asn residues and are related by
pseudo-two-fold symmetry (Figure 4a). The salt triads are located at the entrance
(cytoplasmic side) and exit (stromal side) of the channel suggesting that the triads might play
a role in substrate recognition. The salt triad close to the cytoplasmic side is formed by the
residues K236, E288 and N293 whereas the salt triad close to stromal side is formed by
K107, E172 and N177 (Figure 4b). Interestingly, K107 and K236 lies on α1 and α2
respectively. We have observed that out of the three residues forming the salt triad only the
lysine residues are found at 4.0 Å vicinity of the channel. This suggest that the only
positively charged residue of the triad, lysine probably participates in the recognition of the
negatively charged substrate at the entrance of the channel. To substantiate our claim we have
done stopped flow light scattering studies using proteoliposomes by mutating the K107
residue to alanine (A) and K236 to glutamic acid (E), one at a time. The mutations were
chosen in such a way that the salt triad formation is broken. The results of the light scattering
experiments showed that the both the mutant proteins could not transport the nitrite ion (NO2-
) across the liposome whereas the wildtype proteins aided the movement of NO2- (Figure 5b).
The in-vitro studies prove that lysine residues in the salt triads is an important residue
assisting in the movement of NO2- across the channel and establishes the salt triads as
possible gating regions. The residues forming the salt triad are identical in both NAR1.1 and
NAR1.5 which is consistent with the HSC. The residues forming the salt triad at the entrance
86
of the channel are highly conserved in all the FNT family proteins whose structures are
known but the residues that form the other salt triad are less conserved. This suggests that the
salt triad at the entrance of the channel (cytoplasmic side) is the possible recognition site
where substrate selection occurs which is in agreement with the functional role of this protein
in aiding the movement of NO2- from cytoplasm to stroma.
The narrowest region of the channel is formed by the constriction site near the
cytoplasmic side CS1 with a pore radius of 0.95 Å (chain A of NAR1.1) (Figure 4a). CS1 is
formed by two hydrophobic residues F159, F282 and a charged residue H289 (Figure 4b). All
the three residues are highly conserved in the member of FNT family. Very small pore size at
CS1 suggested that NO2- cannot pass through this narrowest pore region without a possible
electrostatic interaction with H289. The other two residues being hydrophobic cannot form
electrostatic interactions. It is also interesting to note that H289 is the only charged residue
found in the entire middle region of the channel. This indicates that H289 might be playing a
key role in the movement of NO2- towards the stroma. To study its impact we mutated H289
to hydrophobic residue alanine (A). Surprisingly, stopped flow light scattering studies carried
out using the alanine mutant (H289A) failed to transport NO2- (Figure 5b). Alanine being a
smaller residue meant that the mutated protein had a bigger pore radius at CS1. But there was
no evidence of substrate transport. This strengthened our theory that charged H289 residue
interacts with the NO2- and helps it move past the narrowest region of the channel, CS1. This
indicates that Phe-Phe-His forms a gate close to the cytoplasmic side of the protein and acts
as a filter to select NO2-. However its exact modus operandi is still unknown.
Conclusions
Nar1 multigene family of Chlamydomonas reinhardtii encodes six proteins belonging
to the FNT family. Two of these proteins, NAR1.1 and NAR1.5 are found in the chloroplast
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envelope membrane and aids in the transport of anions from cytoplasm towards stroma.
Based on the crystal structures and in-vitro functional studies of NAR1.1 and NAR1.5 we
have identified key residues and elucidated a transport mechanism for FNT family of
proteins. The crystals structure revealed a homopentamer with each monomer forming a
channel facilitating substrate passage. The channel, spans the entire monomer with a funnel
shaped entrance at the cytoplasmic side and two constriction sites in the middle region. Two
salt bridges formed by identical residues Lys-Glu-Asn guard the entrance and the exit of the
channel. In-vitro studies using stopped flow light scattering studies on wildtype proteins have
revealed NO2- as the substrate for NAR1.1 and NAR1.5. The single point mutagenesis studies
have revealed that the lysine residue of the salt triad is essential for the functioning of the
protein as a NO2- channel. This validated our hypothesis that the positively charged lysine
interacts with the negatively charged NO2- and facilitates substrate recognition at the entrance
and exit of the channel. Getting past the salt triad at the cytoplasmic side, NO2- reach the
narrowest region of the channel, constriction site CS1 formed by Phe-Phe-His residues.
Crystal structure of NAR1.1 indicates that the pore radius at CS1 is too small for the NO2- to
pass through. Our results showed that mutating the histidine residue to alanine leaves the
channel incapable of transporting NO2-. This unambiguously proves that positively charged
histidine residue is essential for the functioning of the channel and interacts with the
negatively charged NO2- and helps it move past the narrowest region of the pore thus
unravelling the anion transport mechanism of FNT family proteins.
Materials and methods
Cloning, expression and purification of C. reinhardtii NAR1.5
After removing the first 78 residues that forms the chloroplast transit peptide, the full-
length NAR1.5 (residues 79-343) membrane protein containing 6xHis tag at the N-terminus
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was overproduced in E. coli BL21-CodonPlus∆acrB∆ompF cells possessing the pET15b
expression vector. Cells were grown in 12 l of Luria broth medium with 100 µg/ml ampicillin
at 37 °C. When the OD600 nm reached 0.8, the culture was treated with 0.2 mM isopropyl-β-D-
thiogalactopyranoside (IPTG) to induce the expression of NAR1.5, and the cells were
harvested after 6 hr. The collected bacteria were suspended in a buffer containing 20 mM Na-
HEPES (pH 7.5), 300mM NaCl, 20mM ethylenediaminetetraacetic acid (EDTA) and 10%
glycerol and then disrupted with a French pressure cell. The membrane fraction was then
collected and washed with a buffer containing 20 mM Na-HEPES (pH 7.5) and 50mM NaCl.
The membrane protein was then solubilized in a buffer containing 20 mM Na-HEPES (pH
7.5), 20mM Imidazole-HCl (pH 7.2), 50mM NaCl and 2% (w/v) n-dodecyl-β-D-maltoside
(DDM). Insoluble material was removed by ultracentrifugation at 100,000 × g. The extracted
protein was purified with a Ni2+-affinity column. The purified protein was dialyzed and
concentrated to 10 mg/ml in a buffer containing 20 mM Na-HEPES (pH 7.5), 100mM NaCl
and 0.05% DDM. The 6xHis tag at the N terminus was then cleaved by adding 2 U of
thrombin (GE Healthcare) per mg of purified NAR1.5 at room temperature for 20 hr. The
protein was subsequently passed through a Ni2+-affinity column to remove the free 6xHis tag.
A final purification step was performed using a G200 size exclusion column loaded with
buffer solution containing 20 mM Tris-HCl (pH 7.5), 100mM NaCl and 1.1% n-octyl-β-D-
glucopyranoside (β-OG). The purity of the NAR1.5 protein (>95%) was judged using 15%
SDS-PAGE stained with Coomassie Brilliant Blue. The purified protein was then
concentrated to 10 mg/ml in a buffer containing 20 mM Tris-HCl (pH 7.5), 100mM NaCl and
1.1% β-OG.
For 6xHis selenomethionyl-substituted (SeMet)-NAR1.5 protein expression, a 10 ml
LB broth overnight culture containing E. coli BL21-CodonPlus∆acrB∆ompF/pET15b cells
were transferred into 120 ml of LB broth containing 100 μg/ml ampicillin and grown at 37
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°C. When OD600 nm value reached 0.5, cells were harvested by centrifugation at 6,000 rev/min
for 10 min and then washed two times with 20 ml of M9 minimal salts solution. The cells
were re-suspended in 120 ml of M9 media and then transferred into a 12 l pre-warmed M9
solution containing 100 μg/ml ampicillin. The cell culture was incubated at 37 °C with
shaking. When OD600 nm reached 0.4, 100 mg/l of lysine, phenylalanine, and threonine, 50
mg/l isoleucine, leucine, and valine, and 60 mg/l of L-selenomethionine were added. The
culture was induced with 0.2 mM IPTG after 15 min. Cells were then harvested 6 hr after
induction. The procedures for purifying SeMet-NAR1.5 were identical to those of the native
protein.
Cloning, expression and purification of C. reinhardtii NAR1.1
After removing the first 86 residues that forms the chloroplast transit peptide, the
truncated NAR1.1 (residues 87-344) – with 13 amino acids removed from the C-terminus -
membrane protein containing 6xHis tag at the N-terminus was overproduced in E. coli BL21-
CodonPlus∆acrB∆ompF cells possessing the pET15b expression vector. Cells were grown in
12 l of Luria broth medium with 100 µg/ml ampicillin at 37 °C. When the OD600 nm reached
0.8, the culture was treated with 0.2 mM isopropyl-β-D-thiogalactopyranoside (IPTG) to
induce the expression of NAR1.1, and the cells were harvested after 6 hr. The collected
bacteria were suspended in a buffer containing 20 mM Na-HEPES (pH 7.5), 300mM NaCl,
20mM ethylenediaminetetraacetic acid (EDTA) and 10% glycerol and then disrupted with a
French pressure cell. The membrane fraction was then collected and washed with a buffer
containing 20 mM Na-HEPES (pH 7.5) and 50mM NaCl. The membrane protein was then
solubilized in a buffer containing 20 mM Na-HEPES (pH 7.5), 20mM Imidazole-HCl (pH
7.2), 50mM NaCl and 2% (w/v) n-dodecyl-β-D-maltoside (DDM). Insoluble material was
removed by ultracentrifugation at 100,000 × g. The extracted protein was purified with a
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Ni2+-affinity column. The purified protein was dialyzed and concentrated to 10 mg/ml in a
buffer containing 20 mM Na-HEPES (pH 7.5), 100mM NaCl and 0.05% DDM. The 6xHis
tag at the N terminus was then cleaved by adding 2 U of thrombin (GE Healthcare) per mg of
purified NAR1.1 at room temperature for 20 hr. The protein was subsequently passed through
a Ni2+-affinity column to remove the free 6xHis tag. A final purification step was performed
using a G200 size exclusion column loaded with buffer solution containing 20 mM Tris-HCl
(pH 7.5), 100mM NaCl and 1.1% n-octyl-β-D-glucopyranoside (β-OG). The purity of the
NAR1.1 protein (>95%) was judged using 15% SDS-PAGE stained with Coomassie Brilliant
Blue. The purified protein was then concentrated to 10 mg/ml in a buffer containing 20 mM
Tris-HCl (pH 7.5), 100mM NaCl and 1.1% β-OG.
Crystallization of C. reinhardtii NAR1.5
Crystals of the NAR1.5 protein were obtained using hanging-drop vapor diffusion
method.  The NAR1.5 crystals were grown at 25 °C in 24-well plates using the following
procedure. A 0.5 l protein solution containing 10 mg/ml NAR1.5 in 20 mM Na-HEPES (pH
7.5), 100mM NaCl and 1.1% (w/v) β-OG was mixed with a 0.5 l of reservoir solution
containing 35% polyethylene glycol (PEG) 400, 0.05 M Tris-HCl (pH 8.2), 0.05 M Na2SO4,
0.05 M Li2SO4 and 0.005 M NaNO3. The resultant mixture was equilibrated against 500 l of
the reservoir solution at 25 °C. The crystallization conditions for SeMet-NAR1.5 were the
same as those for native NAR1.5. Crystals of both NAR1.5 and SeMet-NAR1.5 grew to a full
size in drops within two weeks. Typically, the dimensions of the crystals were 0.2 mm x 0.2
mm x 0.4 mm. The condition was already cryo-protectant.
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Crystallization of C. reinhardtii NAR1.1
Crystals of the NAR1.1 protein were obtained using hanging-drop vapor diffusion
method.  The NAR1.1 crystals were grown at 25 °C in 24-well plates using the following
procedure. A 0.5 l protein solution containing 10 mg/ml NAR1.5 in 20 mM Na-HEPES (pH
7.5), 100mM NaCl and 1.1% (w/v) β-OG was mixed with a 0.5 l of reservoir solution
containing 43% polyethylene glycol (PEG) 400, 0.1 M Na-MES (pH 6.5), 0.06 M NaCl, 0.05
M Li2SO4. The resultant mixture was equilibrated against 500 l of the reservoir solution at
25 °C. Crystals of both NAR1.1 grew to a full size in drops within a month. Typically, the
dimensions of the crystals were 0.2 mm x 0.2 mm x 0.3 mm. The condition was already cryo-
protectant.
Data Collection, Structural Determination, and Refinement
All diffraction data were collected at 100 K at Beamline 24ID-C located at the
Advanced Photon Source, using a Pilatus 6M detector (Dectris Ltd., Switzerland). Diffraction
data were processed using DENZO and scaled using SCALEPACK [26]. The NAR1.5
crystals belonged to the space group C2 (Table S1). Five NAR1.5 molecules were expected
in the asymmetric unit with a solvent content of 53.96% based on the molecular weight of
NAR1.5 (27.1 kDa). The experimental phases were solved by molecular replacement with
FocA (PDBID: 3Q7K) as the template. The crystals of SeMet-NAR1.5 belong to space group
P21212 with a content of 62.50%. Within the asymmetric unit of SeMet-NAR1.5, 37 selenium
sites were identified using SHELXC and SHELXD [27] as implemented in the HKL2MAP
package [28]. The mature NAR1.5 protein contains eight methionine residues; all were
identified as SeMet sites in each protomer. Single anomalous dispersion (SAD) was
employed to obtain experimental phases using the program PHENIX [30]. The SeMet sites
were then subjected to trace the molecules by anomalous difference Fourier maps, where we
could assure the proper registry of SeMet residues. The initial model, which consisted of
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pentameric molecules, was constructed manually using program Coot [29]. Then the model
was refined using PHENIX [30], leaving 5% of reflections in the Free-R set. Iterations of
refinement using PHENIX [30] and CNS [31] and model building in Coot [29] lead to the
current model, which consists single pentameric structure with a total number of 1,254
residues.
The NAR1.1 crystal belongs to the space group P3121, resulting in two NAR1.1
pentamers (26.0 kDa) in the asymmetric unit with a solvent content of 61.81%. The structure
of NAR1.1 was determined using molecular replacement. The NAR1.5 pentamer model was
used as a template. The resulting phases were then subjected to density modification using
the program RESOLVE [32]. The model was constructed manually by Coot [29] then refined
using PHENIX [30], leaving 5% of reflections in the Free-R set. Iterations of refinement
using PHENIX [30] and CNS [31] and model building in Coot [29] lead to the current model
of the NAR1.1 pentamers, consisting of a total number of 2,536 residues (Table S1).
Site-Directed Mutagenesis
We performed site-directed mutagenesis on residues K107, K236 and H289 of
NAR1.1 to generate single point mutants K107A, K236E and H289A. All oligonucleotides
were purchased from Integrated DNA Technologies in a salt-free grade.
Reconstitution and stopped flow light scattering assay
The purified wild-type NAR1.5, wild-type NAR1.1, NAR1.1 mutants K107A, K236E
and H289A proteins were reconstituted into liposomes made of E. coli polar lipid and egg-
yolk phosphatidylcholine (Avanti Polar Lipids) in a molar ratio of 3:1. In brief, 50 µg of the
purified protein (wild-type or its mutant) was added to 5 mg of lipids dispersed in the
reconstitution buffer containing 20 mM Na-HEPES (pH 7.5) and 100mM NaCl. The protein
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samples were completely incorporated into liposomes as judged by using 15% SDS–PAGE
stained with Coomassie blue. Control liposomes were prepared by following the same
procedure without the addition of protein. The diameter of the proteoliposomes were
measured as 368 ± 60 nm using Malvern Zetasizer Nano ZS.
To measure the nitrite permeability of target proteins and to identify the key residues
involved in the nitrite transport, the liposomes or proteoliposomes were rapidly mixed with
100mM sodium nitrite at equal volume. The change in vesicle size was detected by recording
the light scattering signal at 440 nm. The above experiments were performed on a stopped-
flow apparatus (LS55; PerkinElmer). On the basis of a published protocol [33], changes in
light scattering could be fitted by two exponentials in the equation Y = [a (1 – e-kt) – b] e-µt +
c, where t is time and Y is the signal of light scattering. The first time-constant (k)
corresponds to the rapid water efflux. The second time-constant (µ) corresponds to the
relative rates of swelling again due to nitrite conduction1. The data were analyzed with
Origin.
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Fig. 1. Structure of the Chlamydomonas reinhardtii NAR1.5 (a) Ribbon diagram of a
pentamer of NAR1.5 viewed in the membrane plane. The five protomers are colored
red, blue, orange, purple and green respectively (b) Ribbon diagram of a pentamer of
NAR1.5 as viewed from the top; perpendicular to the plane of the membrane;
cytoplasmic view. (c) Surface electrostatic potential of the NAR1.5 pentamer as
viewed from the cytoplasmic side (top view) (d) Surface electrostatic potential of the
NAR1.5 pentamer as viewed from the stromal side (bottom view). The blue color in
(c) and (d) corresponds to the positively charged patches of the pentamer. The Figure
was prepared using PyMOL (http://www.pymol.sourceforge.net).
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Fig. 2. Structure of the Chlamydomonas reinhardtii NAR1.1 (a) Ribbon
representation of the superimposition of the protomers of the NAR1.5 (red) and
NAR1.1 (yellow) as viewed in the membrane plane. The transmembrane segments
(TMs) and -helices (s) of the protomers are labeled (b) Ribbon diagram of a
pentamer of NAR1.1 as viewed from the top; perpendicular to the plane of the
membrane; cytoplasmic view. (c) Surface electrostatic potential of the NAR1.1
pentamer as viewed from the cytoplasmic side (top view) (d) Surface electrostatic
potential of the NAR1.1 pentamer as viewed from the stromal side (bottom view). The
blue color in (c) and (d) corresponds to the positively charged patches of the pentamer.
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Fig. 3. Channel of NAR1.1 and NAR1.5. (a) Each subunit of NAR1.1 forms a channel
(colored blue, green and red) spanning the entire transmembrane. This channel was
calculated using the program HOLE (36). (b) Electrostatic surface potential properties
of the cytoplasmic and stromal openings of the NAR1.1 channel facilitate the nitrite
transport. (c) Structure profile of the NAR1.1 channel as calculated with HOLE (34).
(d) Each subunit of NAR1.5 forms a channel (colored blue, green and red) spanning
the entire transmembrane. This channel was calculated using the program HOLE (34).
(e) Electrostatic surface potential properties of the cytoplasmic and stromal openings
of the NAR1.5 channel facilitate the nitrite transport. (f) Structure profile of the
NAR1.5 channel as calculated with HOLE (34).
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Fig. 4. Gating regions of NAR1.1 (a) The locations of the gating regions of a protomer
of NAR1.1. The two salt triads; one at the cytoplasmic side and the other at the stromal
side are colored in purple respectively. The residues in green form the narrowest
region of the channel CS1. This channel was calculated using the program CAVER
(http://loschmidt.chemi.muni.cz/caver). (b) K236, E288 and N293 form the
cytoplasmic salt triad. K107, E172 and N177 form the stromal salt triad. F159, F282
and H289 form CS1. The residues colored red are positively charged.
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Fig. 5. Stopped flow light scattering experiment. (a) Protein-free liposomes and
NAR1.1 and NAR1.5 loaded liposomes are mixed with 100mM NaNO2 in a stopped
flow apparatus. In response to high osmotic pressure water molecules diffused through
the lipid, causing vesicle to deflate. The rapid changes in vesicle size are reflected by
change in scattering. Both NAR1.1 and NAR1.5 are permeable to nitrite. (b) Site
generated mutagenesis revealed that H289A, K236E and K107A mutants are not
permeable to nitrite.
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Fig. S1. Stereo view of the electron density maps of NAR1.5 at a resolution of 3.29 Å.
(a) The electron density maps are contoured at 1.2 . The C traces of the NAR1.5
pentamer in the asymmetric unit are included. (b) Anomalous maps of the 37 selenium
sites (contoured at 3 ). Five protomers forming a pentamer of NAR1.5 are found in
the asymmetric unit. Each protomer contributes 8 selenium sites corresponding to the 8
methionines (red). The C traces of the five NAR1.5 monomers are colored green,
white, purple, yellow and blue. (c) Representative section of the electron density in the
vicinity of TMs 1 and 2a of NAR1.5. The electron density (colored white) is contoured
at the 1.2  level and superimposed with the final refined model (light blue, carbon;
red, oxygen; dark blue, nitrogen).
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Fig. S2. Stereo view of the electron density maps of NAR1.1 at a resolution of 2.49 Å.
(a) The electron density maps are contoured at 1.2 . The C traces of the two
NAR1.1 pentamer in the asymmetric unit are included. (b) Representative section of
the electron density in the vicinity of TMs 2a and 5a of NAR1.1. The electron density
(colored white) is contoured at the 1.2  level and superimposed with the final refined
model (green, carbon; red, oxygen; blue, nitrogen).
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CHAPTER 5. GENERAL CONCLUSIONS
The emergence of drug resistant strains of bacterial pathogens has contributed to
increased human casualities [1, 2]. Emerging strains of Mycobacterium tuberculosis and
Campylobacter jejuni show increased resistance towards existing antibiotics [3, 4]. Bacterial
drug efflux pumps are important therapeutic targets for treating pathogens because they help
in pumping drug molecules out of cells, thereby preventing the accumulation of antibiotics
above a certain level [5]. An important objective of this dissertation research is to elucidate
the structural details of drug efflux pump components and the mechanism of their regulation,
with the long term goal of identifying new therapeutic pathways. Equally important for the
future is the identification and characterization of new and more efficient therapeutic targets
to combat infectious pathogens.
In Chapter 2, we explore the structure and mechanism of regulation of the
transcriptional regulator Rv0678 of M. tuberculosis. Rv0678 is a MarR-like transcriptional
regulator that controls the expression of the MmpS5-MmpL5 efflux system [6]. The
MmpS5-MmpL5 efflux system plays a key role in the biosynthesis and export of lipids [7].
Theses lipids are synthesized in the cytoplasm and are transported to the periplasm by the
MmpS5-MmpL5 efflux system, where they are incorporated into the cell wall. Cell wall
remodeling plays a critical role in bacterial defense against drugs and antibiotics. This makes
the MmpS5-MmpL5 system an important therapeutic target. Our crystal structure of Rv0678
revealed the presence of a fortuitous ligand at the binding site, which co-purified with the
protein. GCMS studies revealed the ligand to be 2-stearoylglycerol, which is a fatty acid
glycerol ester. In-vitro studies using electrophoretic mobility shift assay (EMSA) and dye
primer-based DNase I footprint assay showed that Rv0678 controls the expression levels of
MmpS5-MmpL5, MmpS4-MmpL4, and MmpS2-MmpL2 transport systems. EMSA using 1-
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stearoyl-rac-glycerol also showed that the ligand reduces the binding of Rv0678 with DNA.
Fluorescence polarization assays using labelled 26-bp DNA enabled us to determine the
binding constant and helped us identify important residues for Rv0678 DNA binding.
Together with the in-vitro studies the crystal structure of Rv0678 suggests a possible
mechanism for the binding of DNA to Rv0678.
Chapter 3 presents the crystal structure of the outer membrane channel protein,
CmeC, from CmeABC tripartite drug efflux system of Campylobacter jejuni. CmeC was
expressed in E. coli and was purified and crystallized. The crystal diffracted to 2.37 Å
resolution. Three molecules of CmeC comes together to form a trimeric channel in a closed
conformation state. The charge distribution inside the channel is strikingly electronegative,
facilitating the export of antimicrobials such as fluoroquinolones. The Arginine 104 (R104)
residues from different protomers were found to interact with each other and form a gate at
the upper part of the β-barrel, potentially regulating the movement of substrates. The
availability of the crystal structure and identification of important residues of CmeC may
allow us to design novel drugs to block the function of this channel and increase the
antibiotic sensitivity of pathogenic C. jejuni.
Chapter 4 describes the crystal structures and functional characterization of NAR1.1
and NAR1.5 of Chlamydomonas reinhardtii. C. reinhardtii is a photosynthetic green alga
found predominantly in soil, fresh water bodies and sea beds that relies on photosynthesis to
harvest energy of which carbon is an important raw material [8, 9]. C. reinhardtii possesses a
carbon concentrating mechanism (CCM) to survive in carbon limiting conditions. CCM
consists of many proteins found in different locations [10]. NAR1.2, also called LCIA, is a
component of CCM and is believed to assist in the transport of HCO3- across the chloroplast
envelope [11]. Chloroplast envelope membranes also possess two other proteins encoded by
the nar1 multigene family, NAR1.1 and NAR1.5, which are widely believed to transport
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nitrite ions. All three proteins belong to the Formate-Nitrite family (FNT) of proteins which
are widely found in bacteria but are absent in higher order plants [11]. NAR1.1 and NAR1.5
were expressed, purified and crystallized in E. coli. The crystals diffracted to 2.1 Å and 3.1 Å
resolution respectively. The crystal structure shows a pentameric arrangement for both the
proteins, with each monomer possessing a channel that spans the entire protein. Light
scattering studies on proteoliposomes provided evidence that the proteins transport nitrite
(NO2-) ions and identified important residues that could form a possible gating arrangement.
Based on the crystal structure and in vitro studies, we have suggested a possible mechanism
of transport in these channels.
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